Autostimulation	O
of	O
the	O
Epstein-Barr	O
virus	O
BRLF1	B-DNA
promoter	I-DNA
is	O
mediated	O
through	O
consensus	O
Sp1	B-DNA
and	I-DNA
Sp3	I-DNA
binding	I-DNA
sites	I-DNA
.	O

As	O
an	O
essential	O
step	O
in	O
the	O
lytic	O
cascade	O
,	O
the	O
Rta	O
homologues	O
of	O
gammaherpesviruses	O
all	O
activate	O
their	O
own	O
expression	O
.	O

Consistent	O
with	O
this	O
biologic	O
function	O
,	O
the	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
Rta	B-protein
protein	I-protein
powerfully	O
stimulates	O
the	O
promoter	B-DNA
of	O
its	O
own	O
gene	O
,	O
Rp	B-DNA
,	O
in	O
EBV-positive	B-cell_type
B	I-cell_type
cells	I-cell_type
in	O
transient-transfection	O
reporter-based	O
assays	O
.	O

We	O
analyzed	O
the	O
activity	O
of	O
RpCAT	B-DNA
in	O
response	O
to	O
Rta	B-protein
by	O
deletional	O
and	O
site-directed	O
mutagenesis	O
.	O

Two	O
cognate	B-DNA
Sp1	I-DNA
binding	I-DNA
sites	I-DNA
located	O
at	O
-279	O
and	O
-45	O
relative	O
to	O
the	O
transcriptional	B-DNA
start	I-DNA
site	I-DNA
proved	O
crucial	O
for	O
Rta-mediated	O
activation	O
.	O

Previously	O
described	O
binding	O
sites	O
for	O
the	O
cellular	O
transcription	B-protein
factor	I-protein
Zif268	I-protein
and	O
the	O
viral	B-protein
transactivator	I-protein
ZEBRA	I-protein
were	O
found	O
to	O
be	O
dispensable	O
for	O
activation	O
of	O
RpCAT	B-DNA
by	O
Rta	B-protein
.	O

Gel	O
shift	O
analysis	O
,	O
using	O
extracts	O
of	O
B	B-cell_type
cells	I-cell_type
in	O
latency	O
or	O
induced	O
into	O
the	O
lytic	O
cycle	O
,	O
identified	O
Sp1	B-protein
and	O
Sp3	B-protein
as	O
the	O
predominant	O
cellular	B-protein
proteins	I-protein
bound	O
to	O
Rp	B-DNA
near	O
-45	O
.	O

During	O
the	O
lytic	O
cycle	O
,	O
ZEBRA	B-protein
bound	O
Rp	B-DNA
near	O
the	O
Sp1/Sp3	B-DNA
site	I-DNA
.	O

The	O
binding	O
of	O
Sp1	B-protein
and	O
Sp3	B-protein
to	O
Rp	B-DNA
correlated	O
with	O
the	O
reporter	O
activities	O
in	O
the	O
mutagenesis	O
study	O
,	O
establishing	O
a	O
direct	O
link	O
between	O
transcriptional	O
activation	O
of	O
Rp	B-DNA
by	O
Rta	B-protein
and	O
DNA	O
binding	O
by	O
Sp1	B-protein
and/or	O
Sp3	B-protein
.	O

The	O
relative	O
abundance	O
or	O
functional	O
state	O
of	O
the	O
cellular	O
Sp1	B-protein
and	O
Sp3	B-protein
transcription	B-protein
factors	I-protein
may	O
be	O
altered	O
in	O
response	O
to	O
stimuli	O
that	O
induce	O
the	O
BRLF1	B-DNA
promoter	I-DNA
and	O
thereby	O
contribute	O
to	O
the	O
activation	O
of	O
the	O
viral	O
lytic	O
cycle	O
.	O

JOURNAL	NULL
or	NULL
ViRoLOGY	NULL
,	NULL
June	NULL
2001	NULL
,	NULL
p.	NULL
5240-5251	NULL
0022-538	NULL
%	NULL
X/01/	NULL
$	NULL
04.00+0	NULL
-	NULL
DOT	NULL
:	NULL
10.1128/JV1.75.11.5240-5251.2001	NULL
Vol	NULL
.	NULL

75	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Copyright	NULL
Â©	NULL
2001	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Autostimulation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
Virus	NULL
BRLF1	NULL
Promoter	NULL
Is	NULL
Mediated	NULL
through	NULL
Consensus	NULL
Sp1	NULL
and	NULL
Sp3	NULL
Binding	NULL
Sites	NULL
TOBIAS	NULL
RAGOCZY	NULL
'	NULL
anp	NULL
GEORGE	NULL
MILLER**	NULL
Departments	NULL
of	NULL
Molecular	NULL
Biophysics	NULL
and	NULL
Biochemistry	NULL
and	NULL
Pediatrics	NULL
and	NULL
Epidemiology	NULL
and	NULL
Public	NULL
Health	NULL
,	NULL
``	NULL
Yale	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
Connecticut	NULL
06520	NULL
Received	NULL
1	NULL
December	NULL
2000/Accepted	NULL
9	NULL
March	NULL
2001	NULL
As	NULL
an	NULL
essential	NULL
step	NULL
in	NULL
the	NULL
lytic	NULL
cascade	NULL
,	NULL
the	NULL
Rta	NULL
homologues	NULL
of	NULL
gammaherpesviruses	NULL
all	NULL
activate	NULL
their	NULL
own	NULL
expression	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
biologic	NULL
function	NULL
,	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
Rta	NULL
protein	NULL
powerfully	NULL
stimulates	NULL
the	NULL
promoter	NULL
of	NULL
its	NULL
own	NULL
gene	NULL
,	NULL
Rp	NULL
,	NULL
in	NULL
EBV-positive	NULL
B	NULL
cells	NULL
in	NULL
transient-transfection	NULL
reporter-based	NULL
assays	NULL
.	NULL

We	NULL
analyzed	NULL
the	NULL
activity	NULL
of	NULL
RpCAT	NULL
in	NULL
response	NULL
to	NULL
Rta	NULL
by	NULL
deletional	NULL
and	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

Two	NULL
cognate	NULL
Spl	NULL
binding	NULL
sites	NULL
located	NULL
at	NULL
-279	NULL
and	NULL
-45	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
proved	NULL
crucial	NULL
for	NULL
Rta-mediated	NULL
activation	NULL
.	NULL

Previously	NULL
described	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
cellular	NULL
transcription	NULL
factor	NULL
Zif268	NULL
and	NULL
the	NULL
viral	NULL
transactivator	NULL
ZEBRA	NULL
were	NULL
found	NULL
to	NULL
be	NULL
dispensable	NULL
for	NULL
activation	NULL
of	NULL
RpCAT	NULL
by	NULL
Rta	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
,	NULL
using	NULL
extracts	NULL
of	NULL
B	NULL
cells	NULL
in	NULL
latency	NULL
or	NULL
induced	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
,	NULL
identified	NULL
Spl	NULL
and	NULL
Sp3	NULL
as	NULL
the	NULL
predominant	NULL
cellular	NULL
proteins	NULL
bound	NULL
to	NULL
Rp	NULL
near	NULL
-45	NULL
.	NULL

During	NULL
the	NULL
lytic	NULL
cycle	NULL
,	NULL
ZEBRA	NULL
bound	NULL
Rp	NULL
near	NULL
the	NULL
Sp1/Sp3	NULL
site	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
Spl	NULL
and	NULL
Sp3	NULL
to	NULL
Rp	NULL
correlated	NULL
with	NULL
the	NULL
reporter	NULL
activities	NULL
in	NULL
the	NULL
mutagenesis	NULL
study	NULL
,	NULL
establishing	NULL
a	NULL
direct	NULL
link	NULL
between	NULL
transcriptional	NULL
activation	NULL
of	NULL
Rp	NULL
by	NULL
Rta	NULL
and	NULL
DNA	NULL
binding	NULL
by	NULL
Sp1	NULL
and/or	NULL
Sp3	NULL
.	NULL

The	NULL
relative	NULL
abundance	NULL
or	NULL
functional	NULL
state	NULL
of	NULL
the	NULL
cellular	NULL
Sp1	NULL
and	NULL
Sp3	NULL
transcription	NULL
factors	NULL
may	NULL
be	NULL
altered	NULL
in	NULL
response	NULL
to	NULL
stimuli	NULL
that	NULL
induce	NULL
the	NULL
BRLF1	NULL
promoter	NULL
and	NULL
thereby	NULL
contribute	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
viral	NULL
lytic	NULL
cycle	NULL
.	NULL

Upon	NULL
induction	NULL
of	NULL
the	NULL
lytic	NULL
cycle	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
,	NULL
Rp	NULL
and	NULL
Zp	NULL
,	NULL
the	NULL
two	NULL
promoters	NULL
directing	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
immediate-early	NULL
genes	NULL
BRLF1	NULL
and	NULL
BZLF1	NULL
,	NULL
are	NULL
activated	NULL
simultaneously	NULL
(	NULL
15	NULL
,	NULL
76	NULL
)	NULL
.	NULL

Despite	NULL
their	NULL
similar	NULL
temporal	NULL
regulation	NULL
,	NULL
it	NULL
remains	NULL
unclear	NULL
whether	NULL
the	NULL
two	NULL
promoters	NULL
respond	NULL
to	NULL
the	NULL
same	NULL
or	NULL
different	NULL
signaling	NULL
cascades	NULL
.	NULL

Only	NULL
a	NULL
few	NULL
known	NULL
response	NULL
elements	NULL
for	NULL
transcriptional	NULL
activators	NULL
are	NULL
contained	NULL
within	NULL
Rp	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
;	NULL
these	NULL
include	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
cellular	NULL
transcription	NULL
factors	NULL
YY1	NULL
,	NULL
Zif268	NULL
(	NULL
Egr1	NULL
)	NULL
,	NULL
and	NULL
Spl	NULL
and	NULL
the	NULL
viral	NULL
transactivator	NULL
ZEBRA	NULL
,	NULL
the	NULL
product	NULL
of	NULL
BZLF1	NULL
(	NULL
14	NULL
,	NULL
70	NULL
,	NULL
84-86	NULL
)	NULL
.	NULL

YY1	NULL
and	NULL
Sp1	NULL
sites	NULL
,	NULL
as	NULL
well	NULL
as	NULL
ZEBRA	NULL
response	NULL
elements	NULL
(	NULL
ZREs	NULL
)	NULL
,	NULL
are	NULL
also	NULL
present	NULL
in	NULL
Zp	NULL
(	NULL
14	NULL
,	NULL
48	NULL
,	NULL
58	NULL
,	NULL
70	NULL
,	NULL
73	NULL
)	NULL
.	NULL

ZEBRA	NULL
activates	NULL
Rp	NULL
from	NULL
the	NULL
latent	NULL
virus	NULL
,	NULL
presumably	NULL
by	NULL
directly	NULL
binding	NULL
to	NULL
the	NULL
ZREs	NULL
(	NULL
38	NULL
,	NULL
42	NULL
)	NULL
.	NULL

The	NULL
Zif268	NULL
sites	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
phorbol	NULL
ester-mediated	NULL
activation	NULL
of	NULL
Rp	NULL
,	NULL
while	NULL
the	NULL
Sp1	NULL
sites	NULL
were	NULL
shown	NULL
to	NULL
affect	NULL
the	NULL
constitutive	NULL
activity	NULL
of	NULL
Rp	NULL
in	NULL
cultured	NULL
epithelial	NULL
cells	NULL
(	NULL
85	NULL
,	NULL
86	NULL
)	NULL
.	NULL

However	NULL
,	NULL
their	NULL
physiological	NULL
roles	NULL
and	NULL
contributions	NULL
to	NULL
autostimulation	NULL
of	NULL
Rp	NULL
in	NULL
B	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
assessed	NULL
.	NULL

EBV	NULL
remains	NULL
predominantly	NULL
latent	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
whereas	NULL
epithelial	NULL
cells	NULL
are	NULL
more	NULL
permissive	NULL
for	NULL
lytic	NULL
infection	NULL
by	NULL
the	NULL
virus	NULL
(	NULL
5	NULL
,	NULL
43	NULL
,	NULL
57	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
biologic	NULL
obser-vation	NULL
,	NULL
Rp	NULL
reporters	NULL
exhibit	NULL
significantly	NULL
higher	NULL
constitutive	NULL
activities	NULL
in	NULL
epithelial	NULL
tissue	NULL
culture	NULL
than	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
70	NULL
,	NULL
86	NULL
)	NULL
.	NULL

We	NULL
conducted	NULL
an	NULL
analysis	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
Rp	NULL
in	NULL
an	NULL
EBV-positive	NULL
B-cell	NULL
background	NULL
,	NULL
where	NULL
EBV	NULL
naturally	NULL
persists	NULL
in	NULL
a	NULL
latent	NULL
state	NULL
.	NULL

We	NULL
chose	NULL
the	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
cell	NULL
line	NULL
C116	NULL
(	NULL
HHS14-16	NULL
)	NULL
for	NULL
this	NULL
purpose	NULL
,	NULL
since	NULL
the	NULL
EBV	NULL
contained	NULL
in	NULL
these	NULL
cells	NULL
is	NULL
tightly	NULL
latent	NULL
and	NULL
yet	NULL
can	NULL
be	NULL
induced	NULL
efficiently	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
333	NULL
Cedar	NULL
St.	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06520	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
203	NULL
)	NULL
785-4758	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
203	NULL
)	NULL
785-6961	NULL
.	NULL

E-mail	NULL
:	NULL
George	NULL
Miller	NULL
@	NULL
yale.edu	NULL
.	NULL

5240	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
by	NULL
chemical	NULL
stimuli	NULL
or	NULL
by	NULL
transfection	NULL
of	NULL
ZEBRA	NULL
or	NULL
Rta	NULL
expression	NULL
vectors	NULL
(	NULL
30	NULL
,	NULL
62	NULL
,	NULL
80	NULL
)	NULL
.	NULL

RpCAT	NULL
reporters	NULL
are	NULL
not	NULL
constitutively	NULL
active	NULL
in	NULL
CI16	NULL
cells	NULL
and	NULL
thus	NULL
accurately	NULL
reflect	NULL
the	NULL
behavior	NULL
of	NULL
the	NULL
endogenous	NULL
promoter	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
these	NULL
cells	NULL
Rta	NULL
activates	NULL
Rp	NULL
both	NULL
in	NULL
the	NULL
endogenous	NULL
virus	NULL
and	NULL
when	NULL
presented	NULL
as	NULL
a	NULL
reporter	NULL
construct	NULL
(	NULL
63	NULL
)	NULL
.	NULL

Since	NULL
Rp	NULL
lacks	NULL
cognate	NULL
binding	NULL
sites	NULL
for	NULL
Rta	NULL
,	NULL
the	NULL
mechanism	NULL
of	NULL
autostimulation	NULL
of	NULL
Rp	NULL
must	NULL
be	NULL
indirect	NULL
.	NULL

Extensive	NULL
mutagenesis	NULL
was	NULL
performed	NULL
in	NULL
order	NULL
to	NULL
identify	NULL
cis	NULL
elements	NULL
that	NULL
make	NULL
Rp	NULL
sensitive	NULL
to	NULL
activation	NULL
by	NULL
Rta	NULL
.	NULL

Two	NULL
Spl	NULL
sites	NULL
contained	NULL
within	NULL
the	NULL
-299/+58	NULL
promoter	NULL
fragment	NULL
,	NULL
as	NULL
well	NULL
as	NULL
sequences	NULL
between	NULL
+15	NULL
and	NULL
+30	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
,	NULL
proved	NULL
crucial	NULL
for	NULL
efficient	NULL
autostimulation	NULL
of	NULL
Rp	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
using	NULL
extracts	NULL
of	NULL
uninduced	NULL
and	NULL
C116	NULL
cells	NULL
induced	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
confirmed	NULL
that	NULL
Spl	NULL
and	NULL
Sp3	NULL
were	NULL
the	NULL
predominant	NULL
factors	NULL
binding	NULL
to	NULL
a	NULL
promoter	NULL
fragment	NULL
containing	NULL
one	NULL
of	NULL
the	NULL
Sp1	NULL
sites	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
ubiquitous	NULL
housekeeping	NULL
genes	NULL
Spl	NULL
and	NULL
Sp3	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
EBV	NULL
immediate-early	NULL
genes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

HH514-16	NULL
(	NULL
C116	NULL
)	NULL
is	NULL
a	NULL
clonal	NULL
derivative	NULL
of	NULL
the	NULL
P3J-HR-1	NULL
B-cell	NULL
line	NULL
derived	NULL
from	NULL
an	NULL
EBV-positive	NULL
BL	NULL
that	NULL
is	NULL
permissive	NULL
for	NULL
viral	NULL
replication	NULL
(	NULL
62	NULL
)	NULL
;	NULL
Raji	NULL
is	NULL
a	NULL
human	NULL
B-cell	NULL
line	NULL
derived	NULL
from	NULL
a	NULL
BL	NULL
containing	NULL
an	NULL
EBV	NULL
strain	NULL
that	NULL
is	NULL
defective	NULL
for	NULL
DNA	NULL
replication	NULL
and	NULL
late	NULL
gene	NULL
expression	NULL
(	NULL
61	NULL
)	NULL
;	NULL
and	NULL
B95-8	NULL
is	NULL
a	NULL
marmoset	NULL
B-cell	NULL
line	NULL
transformed	NULL
with	NULL
EBV	NULL
(	NULL
55	NULL
)	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
at	NULL
37Â°C	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
8	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Chemical	NULL
induction	NULL
.	NULL

Cells	NULL
were	NULL
subcultured	NULL
2	NULL
to	NULL
3	NULL
days	NULL
prior	NULL
to	NULL
drug	NULL
treatment	NULL
or	NULL
transfection	NULL
.	NULL

Drug	NULL
treatment	NULL
consisted	NULL
of	NULL
the	NULL
addition	NULL
of	NULL
10	NULL
ng	NULL
of	NULL
tetradeca-noylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
3	NULL
mM	NULL
sodium	NULL
butyrate	NULL
,	NULL
or	NULL
both	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

Trichostatin	NULL
A	NULL
was	NULL
added	NULL
to	NULL
5	NULL
nM	NULL
.	NULL

Expression	NULL
vectors	NULL
and	NULL
reporter	NULL
plasmids	NULL
.	NULL

The	NULL
ZEBRA	NULL
expression	NULL
vector	NULL
pBXG1-genomic	NULL
Z	NULL
and	NULL
its	NULL
parent	NULL
vector	NULL
pBXG1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
Rta	NULL
expression	NULL
vector	NULL
RTS15	NULL
(	NULL
pRTS/Rta	NULL
)	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
RTS15AHIII	NULL
(	NULL
pRTS	NULL
)	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
,	NULL
63	NULL
)	NULL
.	NULL

The	NULL
RpCAT	NULL
deletion	NULL
mutants	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
,	NULL
based	NULL
on	NULL
the	NULL
RpCAT	NULL
(	NULL
-962/+58	NULL
)	NULL
construct	NULL
(	NULL
63	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
control	NULL
vector	NULL
pGL2	NULL
basic+	NULL
HMP	NULL
has	NULL
been	NULL
described	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Site-directed	NULL
muta-	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
NF1	NULL
-850	NULL
-661	NULL
497-425	NULL
-335	NULL
-279	NULL
YY1	NULL
ZRE	NULL
-212	NULL
191-163	NULL
-147	NULL
-123	NULL
AUTOSTIMULATION	NULL
OF	NULL
EBV	NULL
BRLFI	NULL
PROMOTER	NULL
-	NULL
5241	NULL
+1	NULL
ZRE	NULL
TATA	NULL
USF	NULL
Z1	NULL
Zif	NULL
USF	NULL
Sp1	NULL
-79	NULL
45	NULL
41	NULL
-31	NULL
-26	NULL
-	NULL
+4	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Map	NULL
of	NULL
RpCAT	NULL
.	NULL

RpCAT	NULL
reporter	NULL
construct	NULL
used	NULL
for	NULL
mutagenesis	NULL
analysis	NULL
.	NULL

Boxes	NULL
and	NULL
ovals	NULL
represent	NULL
previously	NULL
documented	NULL
and	NULL
putative	NULL
(	NULL
E-boxes	NULL
)	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
respectively	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
22	NULL
,	NULL
27-29	NULL
)	NULL
.	NULL

Numbers	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
3	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
cis	NULL
elements	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
rightward	NULL
arrow	NULL
)	NULL
.	NULL

tions	NULL
were	NULL
introduced	NULL
using	NULL
the	NULL
Quickchange	NULL
mutagenesis	NULL
kit	NULL
(	NULL
Stratagene	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

All	NULL
mutations	NULL
were	NULL
confirmed	NULL
by	NULL
sequencing	NULL
the	NULL
reporter	NULL
constructs	NULL
.	NULL

Oligonucleotide	NULL
primer	NULL
sequences	NULL
are	NULL
available	NULL
upon	NULL
request	NULL
.	NULL

Transfections	NULL
.	NULL

Transfections	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
electroporation	NULL
(	NULL
69	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
1.5	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
0.4	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
were	NULL
exposed	NULL
to	NULL
960	NULL
wF	NULL
and	NULL
250	NULL
V	NULL
in	NULL
electroporation	NULL
cuvettes	NULL
with	NULL
a	NULL
0.4-cm	NULL
gap	NULL
using	NULL
a	NULL
BioRad	NULL
gene	NULL
pulser	NULL
,	NULL
and	NULL
10	NULL
g	NULL
of	NULL
reporter	NULL
DNA	NULL
plus	NULL
5	NULL
ug	NULL
of	NULL
expression	NULL
vector	NULL
pRTS/Rta	NULL
or	NULL
pRTS	NULL
were	NULL
used	NULL
;	NULL
1	NULL
ag	NULL
of	NULL
pGL2	NULL
basic+	NULL
HMP	NULL
was	NULL
included	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
Reporter	NULL
assays	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
69	NULL
)	NULL
.	NULL

CAT	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
determined	NULL
72	NULL
h	NULL
following	NULL
transfection	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
at	NULL
least	NULL
two	NULL
separate	NULL
transfections	NULL
.	NULL

Protein	NULL
extracts	NULL
and	NULL
Western	NULL
blots	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
at	NULL
10Â°	NULL
cells/10	NULL
pl	NULL
.	NULL

Prior	NULL
to	NULL
separation	NULL
by	NULL
SDS-12	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
samples	NULL
(	NULL
20	NULL
wl	NULL
)	NULL
were	NULL
heated	NULL
to	NULL
100Â°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Following	NULL
electrophoresis	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
by	NULL
electroblotting	NULL
and	NULL
blocked	NULL
in	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
overnight	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
antiserum	NULL
diluted	NULL
in	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
at	NULL
25Â°C	NULL
for	NULL
2	NULL
h	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
for	NULL
10	NULL
min	NULL
in	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
-200	NULL
mM	NULL
NaCl-5	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
incubated	NULL
with	NULL
[	NULL
***I-	NULL
]	NULL
protein	NULL
A	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
washed	NULL
again	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
exposed	NULL
overnight	NULL
with	NULL
intensifying	NULL
screens	NULL
to	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
at	NULL
-70Â°C	NULL
.	NULL

Cell	NULL
extracts	NULL
for	NULL
EMSA	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
for	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
untreated	NULL
,	NULL
chemically	NULL
induced	NULL
,	NULL
or	NULL
transfected	NULL
)	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
collected	NULL
again	NULL
by	NULL
centrifugation	NULL
.	NULL

Pellets	NULL
containing	NULL
1.5	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
flash-frozen	NULL
and	NULL
resuspended	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
0.42	NULL
M	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
2	NULL
jg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
spun	NULL
at	NULL
90,000	NULL
rpm	NULL
at	NULL
4Â°C	NULL
for	NULL
15	NULL
min	NULL
using	NULL
a	NULL
TLA100	NULL
rotor	NULL
(	NULL
Beckmann	NULL
)	NULL
in	NULL
a	NULL
benchtop	NULL
ultracentrifuge	NULL
(	NULL
Beckmann	NULL
Optima	NULL
TLX	NULL
)	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
aliquoted	NULL
,	NULL
flash-frozen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80Â°C	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
9	NULL
)	NULL
.	NULL

EMSA	NULL
.	NULL

Annealed	NULL
double-stranded	NULL
oligonucleotides	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
Â°Â°P	NULL
using	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
}	NULL
.	NULL

Binding	NULL
reactions	NULL
contained	NULL
7	NULL
or	NULL
10	NULL
g	NULL
of	NULL
cell	NULL
protein	NULL
in	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
-50	NULL
mM	NULL
NaCl-2	NULL
mM	NULL
MgCl1	NULL
,	NULL
-2.5	NULL
wM	NULL
Zn	NULL
$	NULL
0	NULL
,	NULL
-0.5	NULL
mM	NULL
EDTA-1	NULL
mM	NULL
DTT-15	NULL
%	NULL
glycerol	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
.	NULL

Following	NULL
an	NULL
incubation	NULL
of	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
30,000	NULL
to	NULL
50,000	NULL
cpm	NULL
of	NULL
labeled	NULL
oligonucleotide	NULL
and	NULL
0.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
were	NULL
added	NULL
per	NULL
reaction	NULL
.	NULL

Reactions	NULL
with	NULL
competitor	NULL
DNA	NULL
contained	NULL
a	NULL
500-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
in	NULL
the	NULL
initial	NULL
reaction	NULL
mix	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
antisera	NULL
were	NULL
added	NULL
5	NULL
min	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
,	NULL
and	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
continued	NULL
for	NULL
10	NULL
min	NULL
.	NULL

All	NULL
antisera	NULL
used	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
a-Rta	NULL
(	NULL
63	NULL
)	NULL
and	NULL
a-ZEBRA	NULL
(	NULL
36	NULL
)	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
,	NULL
when	NULL
available	NULL
as	NULL
TransCruz	NULL
antiserum	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
run	NULL
at	NULL
200	NULL
to	NULL
280	NULL
V.	NULL
Gels	NULL
were	NULL
dried	NULL
on	NULL
3MM	NULL
Whatman	NULL
paper	NULL
under	NULL
vacuum	NULL
and	NULL
exposed	NULL
to	NULL
autoradiography	NULL
film	NULL
overnight	NULL
.	NULL

RESULTS	NULL
Responsiveness	NULL
of	NULL
RpCAT	NULL
to	NULL
Rta	NULL
is	NULL
retained	NULL
within	NULL
the	NULL
-299/+30	NULL
fragment	NULL
.	NULL

Figure	NULL
1	NULL
illustrates	NULL
the	NULL
described	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
present	NULL
in	NULL
Rp	NULL
.	NULL

To	NULL
evaluate	NULL
their	NULL
contributions	NULL
to	NULL
autostimulation	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
series	NULL
of	NULL
5	NULL
'	NULL
deletional	NULL
mutants	NULL
of	NULL
RpCAT	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
and	NULL
examined	NULL
their	NULL
activation	NULL
by	NULL
Rta	NULL
in	NULL
C116	NULL
cells	NULL
.	NULL

An	NULL
initial	NULL
series	NULL
of	NULL
large	NULL
progressive	NULL
5	NULL
'	NULL
deletions	NULL
revealed	NULL
that	NULL
maximal	NULL
response	NULL
to	NULL
Rta	NULL
was	NULL
maintained	NULL
in	NULL
a	NULL
fragment	NULL
of	NULL
Rp	NULL
containing	NULL
-299	NULL
to	NULL
+58	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Further	NULL
analysis	NULL
of	NULL
constructs	NULL
with	NULL
shorter	NULL
deletions	NULL
between	NULL
position	NULL
-299	NULL
and	NULL
the	NULL
TATA	NULL
box	NULL
revealed	NULL
a	NULL
steady	NULL
decrease	NULL
in	NULL
response	NULL
to	NULL
Rta	NULL
with	NULL
the	NULL
loss	NULL
of	NULL
sequences	NULL
down	NULL
to	NULL
-140	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
activity	NULL
,	NULL
to	NULL
the	NULL
same	NULL
level	NULL
as	NULL
the	NULL
-299/+58	NULL
construct	NULL
,	NULL
with	NULL
the	NULL
-59/+58	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
increase	NULL
in	NULL
sensitivity	NULL
of	NULL
the	NULL
-59/+58	NULL
fragment	NULL
to	NULL
Rta	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
background	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Rta	NULL
.	NULL

This	NULL
resulted	NULL
in	NULL
stimulation	NULL
of	NULL
the	NULL
-59/+58	NULL
reporter	NULL
by	NULL
Rta	NULL
of	NULL
only	NULL
15-fold	NULL
,	NULL
compared	NULL
with	NULL
a	NULL
64-fold	NULL
stimulation	NULL
of	NULL
RpCAT	NULL
(	NULL
-299/+58	NULL
)	NULL
.	NULL

Considering	NULL
that	NULL
-299/+58	NULL
was	NULL
activated	NULL
by	NULL
Rta	NULL
to	NULL
even	NULL
higher	NULL
levels	NULL
than	NULL
the	NULL
``	NULL
full-length	NULL
``	NULL
-962/+-58	NULL
promoter	NULL
while	NULL
maintaining	NULL
a	NULL
low	NULL
background	NULL
,	NULL
it	NULL
was	NULL
assumed	NULL
that	NULL
the	NULL
-299/+58	NULL
sequence	NULL
contains	NULL
relevant	NULL
cis	NULL
elements	NULL
conferring	NULL
positive	NULL
response	NULL
to	NULL
Rta	NULL
.	NULL

A	NULL
series	NULL
of	NULL
downstream	NULL
deletions	NULL
were	NULL
generated	NULL
in	NULL
the	NULL
context	NULL
of	NULL
Rp	NULL
-299	NULL
to	NULL
assess	NULL
the	NULL
importance	NULL
of	NULL
sequences	NULL
3	NULL
'	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
RpCAT	NULL
by	NULL
Rta	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
construct	NULL
was	NULL
greatly	NULL
reduced	NULL
upon	NULL
loss	NULL
of	NULL
sequences	NULL
between	NULL
+15	NULL
and	NULL
+30	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

Further	NULL
3	NULL
'	NULL
deletions	NULL
invading	NULL
the	NULL
region	NULL
from	NULL
+30	NULL
to	NULL
+58	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
response	NULL
of	NULL
RpCAT	NULL
to	NULL
Rta	NULL
.	NULL

The	NULL
data	NULL
demonstrate	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
5	NULL
'	NULL
region	NULL
beginning	NULL
at	NULL
-299	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
,	NULL
3	NULL
'	NULL
sequences	NULL
between	NULL
+15	NULL
and	NULL
+30	NULL
are	NULL
needed	NULL
for	NULL
efficient	NULL
activation	NULL
of	NULL
RpCAT	NULL
by	NULL
Rta	NULL
.	NULL

Two	NULL
Spl	NULL
sites	NULL
within	NULL
Rp	NULL
are	NULL
crucial	NULL
for	NULL
activation	NULL
by	NULL
Rta	NULL
.	NULL

Liu	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
Rta	NULL
may	NULL
indirectly	NULL
activate	NULL
some	NULL
EBV	NULL
promoters	NULL
lacking	NULL
Rta	NULL
response	NULL
elements	NULL
(	NULL
RREs	NULL
)	NULL
,	NULL
such	NULL
as	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
viral	NULL
DNA	NULL
polymerase	NULL
,	NULL
via	NULL
the	NULL
upstream	NULL
stimulating	NULL
factor	NULL
(	NULL
USF	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
E-box	NULL
DNA	NULL
sequences	NULL
of	NULL
the	NULL
consensus	NULL
CANNTG	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
that	NULL
Rp	NULL
contains	NULL
several	NULL
of	NULL
these	NULL
sequences	NULL
;	NULL
the	NULL
two	NULL
most	NULL
proximal	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
fall	NULL
within	NULL
the	NULL
-299/+58	NULL
region	NULL
at	NULL
-79	NULL
and	NULL
-163	NULL
.	NULL

However	NULL
,	NULL
mutation	NULL
of	NULL
these	NULL
two	NULL
E-boxes	NULL
,	NULL
individually	NULL
or	NULL
together	NULL
,	NULL
did	NULL
not	NULL
negatively	NULL
affect	NULL
the	NULL
activation	NULL
of	NULL
RpCAT	NULL
-299/+58	NULL
by	NULL
Rta	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
E-boxes	NULL
are	NULL
therefore	NULL
unlikely	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
autostimulation	NULL
of	NULL
Rp	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
two	NULL
E-boxes	NULL
,	NULL
the	NULL
-299/+58	NULL
fragment	NULL
of	NULL
Rp	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
several	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

These	NULL
include	NULL
two	NULL
Sp1	NULL
binding	NULL
sites	NULL
at	NULL
-45	NULL
and	NULL
-279	NULL
,	NULL
two	NULL
Zif268	NULL
sites	NULL
at	NULL
-41	NULL
and	NULL
-123	NULL
,	NULL
the	NULL
proximal	NULL
site	NULL
of	NULL
which	NULL
overlaps	NULL
one	NULL
of	NULL
the	NULL
Sp1	NULL
sites	NULL
,	NULL
and	NULL
two	NULL
ZREs	NULL
,	NULL
ZIIIA	NULL
at	NULL
-31	NULL
and	NULL
R	NULL
at	NULL
-191	NULL
(	NULL
14	NULL
,	NULL
85	NULL
,	NULL
86	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
sites	NULL
were	NULL
eliminated	NULL
,	NULL
either	NULL
singly	NULL
or	NULL
in	NULL
pairs	NULL
,	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
in	NULL
the	NULL
context	NULL
of	NULL
RpCAT	NULL
-299/+58	NULL
.	NULL

Figure	NULL
3A	NULL
illustrates	NULL
the	NULL
individual	NULL
mutations	NULL
,	NULL
with	NULL
the	NULL
altered	NULL
bases	NULL
indicated	NULL
in	NULL
bold	NULL
.	NULL

The	NULL
5242	NULL
RAGOCZY	NULL
AND	NULL
MILLER	NULL
J.	NULL
VirRou	NULL
.	NULL

Relative	NULL
rok	NULL
,	NULL
10	NULL
a1	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
A	NULL
-962/+58	NULL
[	NULL
BE	NULL
61	NULL
~740/+58	NULL
31	NULL
-574/+58	NULL
E	NULL
75	NULL
-530/+58	NULL
Bs	NULL
,	NULL
74	NULL
-299/+58	NULL
(	NULL
e	NULL
100	NULL
-233/+58	NULL
BBP	NULL
60	NULL
-180/+58	NULL
[	NULL
46	NULL
-140/+58	NULL
Geese	NULL
43	NULL
-90/+58	NULL
EB	NULL
77	NULL
-59/+58	NULL
BEM	NULL
102	NULL
-31/+58	NULL
BBZ	NULL
27	NULL
-299/+45	NULL
@	NULL
R	NULL
ase	NULL
91	NULL
-299/+30	NULL
CEES	NULL
75	NULL
-299/+15	NULL
(	NULL
5	NULL
%	NULL
15	NULL
-299/+4	NULL
GE	NULL
15	NULL
I	NULL
T	NULL
T	NULL
T	NULL
T	NULL
COT	NULL
~1000	NULL
-800	NULL
-600	NULL
400	NULL
-200	NULL
+50	NULL
120	NULL
p	NULL
110	NULL
B	NULL
[	NULL
J	NULL
]	NULL
vector	NULL
C	NULL
110	NULL
100	NULL
-	NULL
-299	NULL
[	NULL
J	NULL
vector	NULL
_.	NULL
M	NULL
Ria	NULL
_	NULL
100	NULL
HJ	NULL
Ria	NULL
is	NULL
3	NULL
90	NULL
F	NULL
$	NULL
$	NULL
70	NULL
T	NULL
%	NULL
Â®	NULL
so	NULL
S	NULL
@	NULL
]	NULL
Â©	NULL
a	NULL
a_	NULL
50	NULL
%	NULL
<	NULL
4	NULL
20	NULL
Â©	NULL
10	NULL
<	NULL
pCAT	NULL
-	NULL
-209	NULL
-	NULL
-530	NULL
-	NULL
-594	NULL
-	NULL
-740	NULL
_	NULL
-962	NULL
Â°	NULL
pCAT	NULL
-32	NULL
.	NULL

-59	NULL
0	NULL
140	NULL
180	NULL
-233	NULL
299	NULL
Fold	NULL
.	NULL

,	NULL
.	NULL

RpoAT	NULL
l	NULL
RpCAT	NULL
pCAT	NULL
-	NULL
458	NULL
00	NULL
+4500	NULL
+3000	NULL
415000	NULL
+4	NULL
Stimulation	NULL
:	NULL
1.8	NULL
_	NULL
60.8	NULL
-	NULL
42.3	NULL
-	NULL
43.7	NULL
|	NULL
37.5	NULL
_	NULL
34.7	NULL
Stimulation	NULL
:	NULL
2.6	NULL
-	NULL
8.6	NULL
154	NULL
24.7	NULL
322	NULL
26.3	NULL
25.7	NULL
64.4	NULL
I	NULL
--	NULL
--	NULL
--	NULL
-	NULL
RpCAT	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
deletions	NULL
on	NULL
the	NULL
responsiveness	NULL
of	NULL
RpCAT	NULL
to	NULL
Rta	NULL
.	NULL

(	NULL
A	NULL
)	NULL
IMlustration	NULL
of	NULL
Rp	NULL
fragments	NULL
with	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
truncations	NULL
used	NULL
in	NULL
deletional	NULL
mutagenesis	NULL
analysis	NULL
.	NULL

Bars	NULL
represent	NULL
Rp	NULL
fragments	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
.	NULL

Designations	NULL
to	NULL
the	NULL
left	NULL
of	NULL
each	NULL
bar	NULL
are	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
of	NULL
Rp	NULL
,	NULL
which	NULL
is	NULL
indicated	NULL
by	NULL
+1	NULL
.	NULL

Relative	NULL
activities	NULL
of	NULL
the	NULL
RpCAT	NULL
constructs	NULL
in	NULL
response	NULL
to	NULL
Rta	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
5	NULL
'	NULL
deletion	NULL
analysis	NULL
of	NULL
RpCAT	NULL
in	NULL
C116	NULL
cells	NULL
.	NULL

(	NULL
D	NULL
)	NULL
3	NULL
'	NULL
deletions	NULL
of	NULL
RpCAT	NULL
.	NULL

Average	NULL
activities	NULL
of	NULL
deletion	NULL
mutants	NULL
are	NULL
relative	NULL
to	NULL
RpCAT	NULL
(	NULL
-299/+58	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Rta	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
reporter	NULL
constructs	NULL
and	NULL
Rta	NULL
expression	NULL
vector	NULL
(	NULL
shaded	NULL
bars	NULL
)	NULL
or	NULL
empty	NULL
control	NULL
vector	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
are	NULL
standardized	NULL
to	NULL
the	NULL
luciferase	NULL
activity	NULL
of	NULL
a	NULL
cotransfected	NULL
HMP	NULL
+pGL2	NULL
construct	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
(	NULL
@	NULL
>	NULL
2	NULL
)	NULL
.	NULL

Below	NULL
the	NULL
graph	NULL
,	NULL
the	NULL
fold	NULL
stimulation	NULL
of	NULL
the	NULL
RpCAT	NULL
vectors	NULL
is	NULL
given	NULL
(	NULL
reporter	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Rta	NULL
divided	NULL
by	NULL
the	NULL
reporter	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Rta	NULL
)	NULL
.	NULL

proximal	NULL
ZRE	NULL
,	NULL
a	NULL
ZIIIA	NULL
site	NULL
,	NULL
overlaps	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

The	NULL
All	NULL
three	NULL
reporters	NULL
with	NULL
mutated	NULL
ZREs	NULL
(	NULL
R	NULL
,	NULL
ZIIIA	NULL
,	NULL
and	NULL
introduced	NULL
mutation	NULL
therefore	NULL
encompassed	NULL
only	NULL
the	NULL
nucleo-	NULL
R+ZIIIA	NULL
)	NULL
were	NULL
stimulated	NULL
slightly	NULL
more	NULL
than	NULL
the	NULL
wild-type	NULL
Rp	NULL
tides	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
response	NULL
element	NULL
.	NULL

Similarly	NULL
,	NULL
attempts	NULL
-299/+58	NULL
construct	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
do	NULL
not	NULL
play	NULL
a	NULL
role	NULL
in	NULL
were	NULL
made	NULL
to	NULL
dissect	NULL
the	NULL
contributions	NULL
of	NULL
the	NULL
overlapping	NULL
Sp1	NULL
the	NULL
response	NULL
of	NULL
Rp	NULL
to	NULL
Rta	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

and	NULL
Zif268	NULL
sites	NULL
commencing	NULL
at	NULL
positions	NULL
-45	NULL
and	NULL
-41	NULL
,	NULL
re-	NULL
Further	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
Sp1	NULL
sites	NULL
and	NULL
not	NULL
the	NULL
spectively	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
for	NULL
details	NULL
)	NULL
.	NULL

Zif268	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
-299/+58	NULL
Rp	NULL
fragment	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
point	NULL
mutations	NULL
within	NULL
Sp1	NULL
sites	NULL
,	NULL
ZEBRA	NULL
,	NULL
and	NULL
Zif268	NULL
response	NULL
elements	NULL
in	NULL
Rp	NULL
on	NULL
activation	NULL
by	NULL
Rta	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Site-directed	NULL
mutations	NULL
in	NULL
RpCAT	NULL
(	NULL
-299/+58	NULL
)	NULL
.	NULL

Boxes	NULL
represent	NULL
the	NULL
response	NULL
elements	NULL
,	NULL
with	NULL
their	NULL
names	NULL
given	NULL
above	NULL
and	NULL
their	NULL
sequence	NULL
in	NULL
the	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
promoter	NULL
given	NULL
below	NULL
.	NULL

The	NULL
mutated	NULL
sequences	NULL
are	NULL
shown	NULL
beneath	NULL
,	NULL
with	NULL
the	NULL
changes	NULL
indicated	NULL
in	NULL
bold	NULL
.	NULL

The	NULL
average	NULL
activity	NULL
relative	NULL
to	NULL
wild-type	NULL
-299/+58	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
below	NULL
the	NULL
mutated	NULL
sequence	NULL
.	NULL

The	NULL
+1	NULL
above	NULL
the	NULL
rightward	NULL
arrow	NULL
above	NULL
the	NULL
schematic	NULL
represents	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
of	NULL
Rp	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Average	NULL
relative	NULL
activity	NULL
of	NULL
RpCAT	NULL
-299/+58	NULL
with	NULL
site-directed	NULL
mutations	NULL
in	NULL
response	NULL
to	NULL
Rta	NULL
in	NULL
C116	NULL
cells	NULL
.	NULL

Bars	NULL
indicate	NULL
the	NULL
average	NULL
activity	NULL
of	NULL
RpCAT	NULL
reporters	NULL
transfected	NULL
into	NULL
C116	NULL
cells	NULL
with	NULL
Rta	NULL
expression	NULL
vector	NULL
(	NULL
shaded	NULL
bars	NULL
)	NULL
or	NULL
empty	NULL
control	NULL
vector	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
and	NULL
are	NULL
relative	NULL
to	NULL
the	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
RpCAT	NULL
reporter	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Rta	NULL
(	NULL
r	NULL
>	NULL
2	NULL
)	NULL
.	NULL

Constructs	NULL
correspond	NULL
to	NULL
those	NULL
illustrated	NULL
in	NULL
panel	NULL
A.	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
Sp1	NULL
II	NULL
CCACCC	NULL
GGTGGG	NULL
l	NULL
A	NULL
-279	NULL
ATTAAT	NULL
TAATTA	NULL
40	NULL
%	NULL
B	NULL
t	NULL
pCAT	NULL
RpCAT	NULL
wt	NULL
ZRE	NULL
ZIIIA	NULL
ZRE	NULL
R	NULL
zre	NULL
|	NULL
R+ZIIIA	NULL
Spit	NULL
-	NULL
[	NULL
1	NULL
(	NULL
ATTAAT	NULL
)	NULL
Spl	NULL
(	NULL
AT	NULL
)	NULL
Spl	NULL
II	NULL
Spl	NULL
I+II	NULL
(	NULL
ATTAAT	NULL
)	NULL
-	NULL
|L	NULL
Zif	NULL
II	NULL
Zif	NULL
I	NULL
(	NULL
TA	NULL
)	NULL
Zif	NULL
I	NULL
(	NULL
CCTA	NULL
)	NULL
spuZif	NULL
|	NULL
(	NULL
ATTA	NULL
)	NULL
ZRE	NULL
R	NULL
TCGCTCA	NULL
AGCGAGT	NULL
A	NULL
-191	NULL
GACTGAC	NULL
CTGACTG	NULL
112	NULL
%	NULL
Sp1	NULL
I	NULL
(	NULL
ATTAAT	NULL
)	NULL
A	NULL
ATGC	NULL
Sp1	NULL
|	NULL
(	NULL
AT	NULL
)	NULL
ACG	NULL
AUTOSTIMULATION	NULL
OF	NULL
EBV	NULL
BRLFI	NULL
PROMOTER	NULL
Zif	NULL
II	NULL
Sp1	NULL
|	NULL
II	NULL
Zif	NULL
|	NULL
TGCCCACTC	NULL
CCCGCCCATGC	NULL
ACGGGTGAG	NULL
GBGCGGGrace	NULL
l	NULL
A	NULL
A	NULL
-	NULL
1	NULL
-123	NULL
5	NULL
41	NULL
ATATCGATA	NULL
TATAGCTAT	NULL
98	NULL
%	NULL
C|AT	NULL
TAATIATGC	NULL
G	NULL
[	NULL
TAATTA	NULL
|TACG	NULL
23	NULL
%	NULL
28	NULL
%	NULL
20	NULL
%	NULL
Sp1/Zif	NULL
(	NULL
AT/TA	NULL
)	NULL
100	NULL
I	NULL
1	NULL
1	NULL
m	NULL
5243	NULL
TATA	NULL
CAT	NULL
GGcTeAlaAAA	NULL
azi	NULL
``	NULL
t	NULL
Sequence	NULL
A	NULL
A	NULL
y-31	NULL
-26	NULL
ACTGCAITAAAA	NULL
TGACGTIATTTT	NULL
115	NULL
%	NULL
CCCEGccecArTA	NULL
)	NULL
,	NULL
4	NULL
!	NULL

0	NULL
129	NULL
%	NULL
146	NULL
%	NULL
l|20	NULL
1:30	NULL
1'60	NULL
180	NULL
80	NULL
100	NULL
120	NULL
140	NULL
160	NULL
180	NULL
5244	NULL
RAGOCZY	NULL
AND	NULL
MILLER	NULL
contributed	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
Rp	NULL
by	NULL
Rta	NULL
.	NULL

Elimination	NULL
of	NULL
the	NULL
distal	NULL
Sp1	NULL
site	NULL
located	NULL
at	NULL
position	NULL
-279	NULL
reduced	NULL
the	NULL
Rp	NULL
response	NULL
to	NULL
40	NULL
%	NULL
relative	NULL
to	NULL
the	NULL
wild-type	NULL
promoter	NULL
,	NULL
while	NULL
a	NULL
6-bp	NULL
mutation	NULL
(	NULL
ATTAAT	NULL
)	NULL
within	NULL
the	NULL
proximal	NULL
Sp1	NULL
site	NULL
I	NULL
reduced	NULL
the	NULL
response	NULL
to	NULL
23	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

A	NULL
2-bp	NULL
mutation	NULL
at	NULL
the	NULL
5	NULL
end	NULL
of	NULL
this	NULL
Sp1	NULL
site	NULL
,	NULL
leaving	NULL
the	NULL
Zif268	NULL
response	NULL
element	NULL
intact	NULL
,	NULL
similarly	NULL
reduced	NULL
Rp	NULL
response	NULL
to	NULL
28	NULL
%	NULL
relative	NULL
to	NULL
the	NULL
wild-type	NULL
promoter	NULL
.	NULL

Removal	NULL
of	NULL
both	NULL
Sp1	NULL
sites	NULL
together	NULL
led	NULL
to	NULL
an	NULL
eight-fold-lower	NULL
response	NULL
(	NULL
12	NULL
%	NULL
)	NULL
of	NULL
Rp	NULL
to	NULL
Rta	NULL
.	NULL

Both	NULL
Sp1	NULL
sites	NULL
were	NULL
therefore	NULL
important	NULL
for	NULL
autostimulation	NULL
of	NULL
Rp	NULL
by	NULL
Rta	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
distal	NULL
Sp1	NULL
site	NULL
,	NULL
alteration	NULL
of	NULL
the	NULL
upstream	NULL
Zif268	NULL
site	NULL
II	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
RpCAT	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
the	NULL
proximal	NULL
Zif268	NULL
site	NULL
was	NULL
more	NULL
complex	NULL
,	NULL
since	NULL
it	NULL
overlaps	NULL
the	NULL
Sp1	NULL
site	NULL
.	NULL

Zif268	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
compete	NULL
with	NULL
Sp1	NULL
for	NULL
DNA	NULL
binding	NULL
on	NULL
overlapping	NULL
sites	NULL
(	NULL
1	NULL
,	NULL
6	NULL
,	NULL
31	NULL
,	NULL
77	NULL
)	NULL
.	NULL

A	NULL
two-base	NULL
change	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
proximal	NULL
Zif268	NULL
site	NULL
(	NULL
at	NULL
position	NULL
-41	NULL
)	NULL
to	NULL
TA	NULL
,	NULL
which	NULL
mutates	NULL
the	NULL
Zif268	NULL
site	NULL
but	NULL
leaves	NULL
the	NULL
core	NULL
Sp1	NULL
sequence	NULL
intact	NULL
,	NULL
increased	NULL
the	NULL
promoter	NULL
activity	NULL
to	NULL
129	NULL
%	NULL
relative	NULL
to	NULL
wild-type	NULL
Rp	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
possible	NULL
loss	NULL
of	NULL
minor	NULL
inhibition	NULL
by	NULL
Zif268	NULL
.	NULL

An	NULL
additional	NULL
mutation	NULL
within	NULL
this	NULL
Zif268	NULL
site	NULL
,	NULL
changing	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
sequence	NULL
from	NULL
ATGC	NULL
(	NULL
wild	NULL
type	NULL
)	NULL
to	NULL
CCTA	NULL
,	NULL
led	NULL
to	NULL
a	NULL
further	NULL
increase	NULL
in	NULL
activity	NULL
to	NULL
146	NULL
%	NULL
.	NULL

This	NULL
enhanced	NULL
activity	NULL
of	NULL
the	NULL
CCTA	NULL
mutation	NULL
may	NULL
also	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
increased	NULL
GC	NULL
content	NULL
surrounding	NULL
the	NULL
Sp1	NULL
core	NULL
element	NULL
,	NULL
thus	NULL
improving	NULL
the	NULL
quality	NULL
of	NULL
the	NULL
Sp1	NULL
site	NULL
.	NULL

As	NULL
a	NULL
final	NULL
test	NULL
of	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
the	NULL
two	NULL
factors	NULL
,	NULL
point	NULL
mutations	NULL
were	NULL
generated	NULL
at	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
Sp1	NULL
site	NULL
and	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
Zif268	NULL
site	NULL
[	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
Sp1/Zif	NULL
(	NULL
AT/TA	NULL
)	NULL
]	NULL
.	NULL

The	NULL
resulting	NULL
promoter	NULL
activity	NULL
(	NULL
20	NULL
%	NULL
)	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
caused	NULL
by	NULL
the	NULL
Sp1	NULL
(	NULL
AT	NULL
)	NULL
mutation	NULL
alone	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
Sp1	NULL
site	NULL
is	NULL
dominant	NULL
over	NULL
the	NULL
overlapping	NULL
Zif268	NULL
element	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
Sp1	NULL
sites	NULL
and	NULL
not	NULL
the	NULL
Zif268	NULL
sites	NULL
contribute	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
Rp	NULL
by	NULL
Rta	NULL
.	NULL

Chemical	NULL
treatment	NULL
does	NULL
not	NULL
induce	NULL
Zif268	NULL
expression	NULL
in	NULL
C116	NULL
cells	NULL
.	NULL

Zalani	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
the	NULL
phorbol	NULL
ester	NULL
TPA	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Zif268	NULL
in	NULL
the	NULL
B-cell	NULL
line	NULL
B95-8	NULL
and	NULL
that	NULL
this	NULL
protein	NULL
was	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
and	NULL
activating	NULL
Rp	NULL
(	NULL
85	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
Zif268	NULL
sites	NULL
within	NULL
Rp	NULL
did	NULL
not	NULL
seem	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
RpCAT	NULL
reporter	NULL
by	NULL
Rta	NULL
in	NULL
C116	NULL
cells	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
significant	NULL
amounts	NULL
of	NULL
Zif268	NULL
were	NULL
expressed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Extracts	NULL
prepared	NULL
from	NULL
C116	NULL
cells	NULL
treated	NULL
with	NULL
several	NULL
inducing	NULL
chemicals	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
Zif268	NULL
and	NULL
the	NULL
immediate-early	NULL
lytic	NULL
proteins	NULL
Rta	NULL
and	NULL
ZEBRA	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
this	NULL
analysis	NULL
was	NULL
also	NULL
performed	NULL
in	NULL
Jijoye	NULL
cells	NULL
,	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
of	NULL
C116	NULL
,	NULL
in	NULL
Raji	NULL
cells	NULL
,	NULL
and	NULL
in	NULL
the	NULL
marmoset	NULL
cell	NULL
line	NULL
B95-8	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
B95-8	NULL
cells	NULL
,	NULL
which	NULL
exhibit	NULL
a	NULL
low	NULL
level	NULL
of	NULL
leaky	NULL
spontaneous	NULL
lytic-cycle	NULL
gene	NULL
expression	NULL
,	NULL
Zif268	NULL
was	NULL
not	NULL
present	NULL
in	NULL
uninduced	NULL
cells	NULL
,	NULL
and	NULL
EBV	NULL
remained	NULL
tightly	NULL
latent	NULL
(	NULL
lanes	NULL
1	NULL
)	NULL
.	NULL

TPA	NULL
treatment	NULL
(	NULL
lanes	NULL
2	NULL
)	NULL
resulted	NULL
in	NULL
strong	NULL
induction	NULL
of	NULL
Zif268	NULL
expression	NULL
in	NULL
Raji	NULL
,	NULL
B95-8	NULL
,	NULL
and	NULL
Jijoye	NULL
cells	NULL
,	NULL
but	NULL
in	NULL
C116	NULL
cells	NULL
Zif268	NULL
remained	NULL
undetectable	NULL
.	NULL

In	NULL
Raji	NULL
and	NULL
B95-8	NULL
cells	NULL
,	NULL
upregulation	NULL
of	NULL
Zif268	NULL
by	NULL
TPA	NULL
was	NULL
accompanied	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
EBV	NULL
lytic	NULL
cycle	NULL
;	NULL
both	NULL
Rta	NULL
and	NULL
ZEBRA	NULL
were	NULL
expressed	NULL
.	NULL

EBV	NULL
was	NULL
not	NULL
induced	NULL
by	NULL
TPA	NULL
in	NULL
C116	NULL
cells	NULL
or	NULL
in	NULL
Jijoye	NULL
cells	NULL
.	NULL

Although	NULL
TPA	NULL
strongly	NULL
activated	NULL
Zif268	NULL
in	NULL
Jijoye	NULL
cells	NULL
,	NULL
it	NULL
did	NULL
not	NULL
do	NULL
so	NULL
in	NULL
CH6	NULL
cells	NULL
.	NULL

Two	NULL
chemical	NULL
agents	NULL
known	NULL
to	NULL
induce	NULL
the	NULL
lytic	NULL
cycle	NULL
in	NULL
CH6	NULL
cells	NULL
,	NULL
sodium	NULL
butyrate	NULL
and	NULL
trichostatin	NULL
A	NULL
,	NULL
efficiently	NULL
stimulated	NULL
J.	NULL
Virou	NULL
.	NULL

U	NULL
T	NULL
B	NULL
A	NULL
U	NULL
T	NULL
OB	NULL
A	NULL
kDa	NULL
Rta	NULL
``	NULL
-	NULL
cep	NULL
-	NULL
84	NULL
-	NULL
84	NULL
Zif	NULL
?	NULL

68	NULL
.	NULL

ZEBRA	NULL
lis	NULL
â	NULL
-	NULL
33.4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
CH6	NULL
Jijoye	NULL
Uo	NULL
T	NULL
OB	NULL
A	NULL
U	NULL
OT	NULL
OB	NULL
A	NULL
Rta	NULL
wite	NULL
.__	NULL
.	NULL

-	NULL
84	NULL
Zif268	NULL
oem	NULL
W	NULL
&	NULL
-	NULL
84	NULL
ZEBRA	NULL
C	NULL
..	NULL
-	NULL
33.4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Raji	NULL
B95-8	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Zif268	NULL
expression	NULL
does	NULL
not	NULL
correlate	NULL
with	NULL
lytic	NULL
cycle	NULL
induction	NULL
in	NULL
C16	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
cell	NULL
extracts	NULL
of	NULL
C116	NULL
,	NULL
Jijoye	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
B95-8	NULL
cells	NULL
that	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
U	NULL
)	NULL
or	NULL
treated	NULL
for	NULL
48	NULL
h	NULL
with	NULL
either	NULL
TPA	NULL
(	NULL
T	NULL
)	NULL
,	NULL
sodium	NULL
butyrate	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
trichostatin	NULL
A	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Immunoblots	NULL
were	NULL
probed	NULL
with	NULL
antibodies	NULL
against	NULL
Rta	NULL
,	NULL
Zif268	NULL
,	NULL
and	NULL
ZEBRA	NULL
.	NULL

the	NULL
expression	NULL
of	NULL
Rta	NULL
and	NULL
ZEBRA	NULL
but	NULL
did	NULL
not	NULL
induce	NULL
Zif268	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
Zif268	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
lytic	NULL
cycle	NULL
of	NULL
EBV	NULL
did	NULL
not	NULL
correlate	NULL
in	NULL
Jijoye	NULL
and	NULL
C16	NULL
cells	NULL
.	NULL

Spl	NULL
and	NULL
Sp3	NULL
are	NULL
the	NULL
predominant	NULL
cellular	NULL
factors	NULL
binding	NULL
to	NULL
Rp	NULL
-64/-28	NULL
.	NULL

The	NULL
mutagenesis	NULL
analysis	NULL
provided	NULL
a	NULL
surprising	NULL
result	NULL
because	NULL
,	NULL
as	NULL
a	NULL
ubiquitous	NULL
housekeeping	NULL
gene	NULL
,	NULL
Spl	NULL
has	NULL
not	NULL
been	NULL
considered	NULL
an	NULL
obvious	NULL
candidate	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
lytic	NULL
cycle	NULL
promoter	NULL
Rp	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
extracts	NULL
of	NULL
uninduced	NULL
and	NULL
induced	NULL
C16	NULL
cells	NULL
to	NULL
determine	NULL
which	NULL
cell	NULL
or	NULL
viral	NULL
factors	NULL
were	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
this	NULL
promoter	NULL
region	NULL
in	NULL
vitro	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
spanning	NULL
Rp	NULL
positions	NULL
-64	NULL
to	NULL
-28	NULL
,	NULL
was	NULL
centered	NULL
around	NULL
the	NULL
proximal	NULL
Spl	NULL
site	NULL
and	NULL
also	NULL
included	NULL
the	NULL
nearby	NULL
ZRE	NULL
ZIIIA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
extracts	NULL
generated	NULL
several	NULL
distinct	NULL
band	NULL
shifts	NULL
,	NULL
labeled	NULL
A	NULL
though	NULL
F	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
patterns	NULL
produced	NULL
by	NULL
uninduced	NULL
and	NULL
chemically	NULL
induced	NULL
cell	NULL
extracts	NULL
were	NULL
identical	NULL
except	NULL
that	NULL
the	NULL
slowest-mobility	NULL
complex	NULL
A	NULL
was	NULL
observed	NULL
only	NULL
with	NULL
induced	NULL
cell	NULL
extract	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
to	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

These	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
supershifts	NULL
using	NULL
antisera	NULL
against	NULL
a	NULL
variety	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
by	NULL
means	NULL
of	NULL
oligonucleotide	NULL
competition	NULL
.	NULL

These	NULL
studies	NULL
showed	NULL
that	NULL
several	NULL
of	NULL
the	NULL
most	NULL
prominent	NULL
DNA-protein	NULL
complexes	NULL
contained	NULL
Spl	NULL
or	NULL
Sp3	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
uninduced	NULL
cell	NULL
extracts	NULL
,	NULL
Â«	NULL
-Sp3	NULL
completely	NULL
supershifted	NULL
complex	NULL
D	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
and	NULL
a	NULL
lower	NULL
portion	NULL
of	NULL
complex	NULL
B	NULL
(	NULL
B	NULL
;	NULL
;	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
while	NULL
Â«	NULL
-Sp1	NULL
supershifted	NULL
a	NULL
higher	NULL
portion	NULL
of	NULL
complex	NULL
B	NULL
(	NULL
B	NULL
,	NULL
;	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
both	NULL
antisera	NULL
efficiently	NULL
supershifted	NULL
both	NULL
components	NULL
of	NULL
complex	NULL
B	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Sp3	NULL
exists	NULL
in	NULL
two	NULL
major	NULL
isoforms	NULL
,	NULL
70	NULL
to	NULL
80	NULL
and	NULL
110	NULL
to	NULL
115	NULL
kDa	NULL
in	NULL
size	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
two	NULL
observed	NULL
protein-DNA	NULL
complexes	NULL
B	NULL
;	NULL
and	NULL
D	NULL
(	NULL
37	NULL
,	NULL
75	NULL
)	NULL
.	NULL

The	NULL
only	NULL
other	NULL
protein	NULL
factor	NULL
to	NULL
be	NULL
identified	NULL
was	NULL
Ku	NULL
in	NULL
complex	NULL
C	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Ku	NULL
binds	NULL
double-stranded	NULL
DNA	NULL
ends	NULL
irrespective	NULL
of	NULL
sequence	NULL
(	NULL
8	NULL
,	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
E2F1	NULL
===	NULL
Sp1	NULL
Zif	NULL
AUTOSTIMULATION	NULL
OF	NULL
EBV	NULL
BRLFI	NULL
PROMOTER	NULL
-	NULL
5245	NULL
GGTTTTATATTGCGAT	NULL
TG	NULL
GCCC	NULL
ICCAAAA	NULL
:	NULL
FATA	NULL
:	NULL
?	NULL

C	NULL
'	NULL
G	NULL
CTAAC	NULL
.	NULL

CGGG	NULL
1	NULL
|	NULL
-70	NULL
-50	NULL
-47	NULL
-45	NULL
1	NULL
-60	NULL
;	NULL
~41	NULL
-64/-35	NULL
-58/-28	NULL
1	NULL
i	NULL
i	NULL
-64/-28	NULL
1	NULL
1	NULL
i	NULL
-58/-35	NULL
ZRE	NULL
qâ	NULL
â	NULL
TATA	NULL
AATGGCTCATAAAAGACCAGTAATCCATGTCAGCCGGCA	NULL
TTACCGAGTATTTTCTGGTCATTAGGTACAGTCGGCCGT	NULL
10	NULL
A1	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
C16	NULL
Rp	NULL
from	NULL
-70	NULL
to	NULL
-1	NULL
.	NULL

Lines	NULL
above	NULL
the	NULL
sequence	NULL
indicate	NULL
the	NULL
extent	NULL
of	NULL
documented	NULL
and	NULL
putative	NULL
(	NULL
EZF1	NULL
)	NULL
cis-active	NULL
response	NULL
elements	NULL
of	NULL
DNA-binding	NULL
factors	NULL
.	NULL

The	NULL
boxes	NULL
indicate	NULL
bases	NULL
that	NULL
have	NULL
been	NULL
changed	NULL
in	NULL
mutant	NULL
gel	NULL
shift	NULL
oligonucleotide	NULL
probes	NULL
:	NULL
CC	NULL
(	NULL
-51/-50	NULL
)	NULL
>	NULL
AT	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
and	NULL
ATGC	NULL
(	NULL
-44/-41	NULL
)	NULL
-	NULL
>	NULL
CCTA	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Below	NULL
the	NULL
sequence	NULL
,	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
in	NULL
gel	NULL
shifts	NULL
is	NULL
indicated	NULL
.	NULL

20	NULL
,	NULL
56	NULL
,	NULL
72	NULL
)	NULL
.	NULL

Rta	NULL
itself	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
any	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
by	NULL
antibody	NULL
supershifts	NULL
or	NULL
competition	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
15	NULL
)	NULL
.	NULL

Spl	NULL
and	NULL
ZEBRA	NULL
occupy	NULL
Rp	NULL
-64	NULL
and	NULL
-28	NULL
together	NULL
in	NULL
complex	NULL
A	NULL
.	NULL

Analysis	NULL
of	NULL
complex	NULL
A	NULL
formed	NULL
by	NULL
extracts	NULL
of	NULL
C116	NULL
cells	NULL
that	NULL
were	NULL
induced	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
revealed	NULL
that	NULL
complex	NULL
A	NULL
contained	NULL
both	NULL
Spl	NULL
and	NULL
ZEBRA	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
support	NULL
this	NULL
conclusion	NULL
.	NULL

In	NULL
extracts	NULL
of	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
transfected	NULL
with	NULL
ZEBRA	NULL
and	NULL
Rta	NULL
expression	NULL
vectors	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
,	NULL
complex	NULL
A	NULL
was	NULL
eliminated	NULL
by	NULL
addition	NULL
of	NULL
Â«	NULL
-ZEBRA	NULL
serum	NULL
(	NULL
the	NULL
signal	NULL
is	NULL
retained	NULL
in	NULL
the	NULL
well	NULL
;	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
DNA	NULL
containing	NULL
the	NULL
high-affinity	NULL
ZIIIB	NULL
ZEBRA	NULL
recognition	NULL
element	NULL
efficiently	NULL
competed	NULL
for	NULL
the	NULL
binding	NULL
activity	NULL
in	NULL
complex	NULL
A	NULL
(	NULL
lane	NULL
14	NULL
)	NULL
.	NULL

Antibody	NULL
against	NULL
Sp1	NULL
also	NULL
supershifted	NULL
complex	NULL
A	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
Spl	NULL
supershifts	NULL
in	NULL
extracts	NULL
of	NULL
uninduced	NULL
versus	NULL
induced	NULL
cells	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
11	NULL
)	NULL
revealed	NULL
an	NULL
enlarged	NULL
supershifted	NULL
band	NULL
with	NULL
the	NULL
extract	NULL
of	NULL
induced	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
additional	NULL
presence	NULL
of	NULL
a	NULL
larger	NULL
complex	NULL
of	NULL
slower	NULL
mobility	NULL
.	NULL

Competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
Sp1	NULL
binding	NULL
motif	NULL
also	NULL
eliminated	NULL
most	NULL
of	NULL
complex	NULL
A	NULL
(	NULL
lane	NULL
13	NULL
)	NULL
,	NULL
confirming	NULL
the	NULL
presence	NULL
of	NULL
Spl	NULL
in	NULL
the	NULL
complex	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
although	NULL
S	NULL
$	NULL
p3	NULL
has	NULL
the	NULL
same	NULL
DNA-binding	NULL
specificity	NULL
as	NULL
Sp1	NULL
,	NULL
it	NULL
was	NULL
not	NULL
contained	NULL
in	NULL
complex	NULL
A	NULL
together	NULL
with	NULL
ZEBRA	NULL
,	NULL
since	NULL
the	NULL
Â«	NULL
-Sp3	NULL
serum	NULL
did	NULL
not	NULL
affect	NULL
this	NULL
complex	NULL
(	NULL
compare	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
11	NULL
)	NULL
.	NULL

On	NULL
a	NULL
higher	NULL
percentage	NULL
gel	NULL
,	NULL
however	NULL
,	NULL
a	NULL
minor	NULL
complex	NULL
consisting	NULL
of	NULL
the	NULL
smaller	NULL
isoform	NULL
of	NULL
$	NULL
p3	NULL
and	NULL
ZEBRA	NULL
migrating	NULL
between	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
could	NULL
be	NULL
detected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
excess	NULL
of	NULL
unlabeled	NULL
DNA	NULL
containing	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
Rta	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
A	NULL
(	NULL
lane	NULL
15	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
controlled	NULL
for	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
competitor	NULL
oligonucleotides	NULL
and	NULL
also	NULL
showed	NULL
that	NULL
Rta	NULL
was	NULL
not	NULL
present	NULL
in	NULL
complex	NULL
A	NULL
.	NULL

The	NULL
competition	NULL
experiments	NULL
also	NULL
revealed	NULL
that	NULL
complex	NULL
E	NULL
was	NULL
the	NULL
result	NULL
of	NULL
non-specific	NULL
DNA-binding	NULL
activity	NULL
,	NULL
as	NULL
all	NULL
three	NULL
unrelated	NULL
oligonucleotides	NULL
competed	NULL
for	NULL
it	NULL
with	NULL
equal	NULL
efficiency	NULL
.	NULL

ZEBRA	NULL
and	NULL
Sp3	NULL
form	NULL
distinct	NULL
components	NULL
of	NULL
complex	NULL
D	NULL
in	NULL
induced	NULL
cell	NULL
extracts	NULL
.	NULL

The	NULL
EMSA	NULL
experiments	NULL
also	NULL
showed	NULL
that	NULL
complex	NULL
D	NULL
formed	NULL
with	NULL
extracts	NULL
of	NULL
C116	NULL
cells	NULL
in	NULL
the	NULL
lytic	NULL
EBV	NULL
cycle	NULL
contained	NULL
two	NULL
subcomplexes	NULL
,	NULL
one	NULL
formed	NULL
by	NULL
Sp3	NULL
and	NULL
the	NULL
other	NULL
by	NULL
ZEBRA	NULL
.	NULL

The	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
Sp1/Sp3	NULL
binding	NULL
site	NULL
completely	NULL
competed	NULL
for	NULL
formation	NULL
of	NULL
complex	NULL
D	NULL
generated	NULL
by	NULL
extracts	NULL
of	NULL
latently	NULL
infected	NULL
cells	NULL
but	NULL
failed	NULL
to	NULL
eliminate	NULL
a	NULL
significant	NULL
portion	NULL
of	NULL
complex	NULL
D	NULL
formed	NULL
by	NULL
extracts	NULL
of	NULL
lytically	NULL
induced	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
compare	NULL
lanes	NULL
6	NULL
and	NULL
13	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
Â«	NULL
-Sp3	NULL
,	NULL
which	NULL
completely	NULL
supershifted	NULL
complex	NULL
D	NULL
in	NULL
extracts	NULL
of	NULL
uninduced	NULL
cells	NULL
,	NULL
left	NULL
a	NULL
significant	NULL
portion	NULL
of	NULL
complex	NULL
D	NULL
formed	NULL
by	NULL
extracts	NULL
of	NULL
induced	NULL
cells	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
induced	NULL
cell	NULL
extract	NULL
contained	NULL
an	NULL
additional	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
Rp	NULL
-64/-28	NULL
probe	NULL
in	NULL
complex	NULL
D	NULL
that	NULL
was	NULL
not	NULL
present	NULL
in	NULL
uninduced	NULL
CIH6	NULL
cells	NULL
.	NULL

Unlike	NULL
the	NULL
situation	NULL
described	NULL
for	NULL
complex	NULL
A	NULL
,	NULL
this	NULL
factor	NULL
is	NULL
unlikely	NULL
to	NULL
occupy	NULL
the	NULL
same	NULL
DNA	NULL
fragment	NULL
as	NULL
either	NULL
Sp1	NULL
or	NULL
A	NULL
-	NULL
>	NULL
B	NULL
-	NULL
>	NULL
H..-C	NULL
-	NULL
>	NULL
D	NULL
-	NULL
Â»	NULL
bag	NULL
E	NULL
-	NULL
>	NULL
wand	NULL
Cit	NULL
)	NULL
Â»	NULL
dunt	NULL
F	NULL
-	NULL
Â»	NULL
extract	NULL
+	NULL
U	NULL
TB	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Major	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
on	NULL
Rp	NULL
-64/-28	NULL
.	NULL

EMSA	NULL
pattern	NULL
of	NULL
C116	NULL
extracts	NULL
binding	NULL
to	NULL
an	NULL
Rp	NULL
-64/-28	NULL
oligonucleotide	NULL
.	NULL

Either	NULL
5	NULL
or	NULL
10	NULL
pg	NULL
of	NULL
total	NULL
cell	NULL
protein	NULL
from	NULL
uninduced	NULL
(	NULL
U	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
chemically	NULL
induced	NULL
with	NULL
TPA	NULL
and	NULL
sodium	NULL
butyrate	NULL
(	NULL
TB	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
C116	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

Complexes	NULL
are	NULL
labeled	NULL
with	NULL
the	NULL
letters	NULL
A	NULL
to	NULL
F	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Probe	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
probe	NULL
alone	NULL
.	NULL

-	NULL
<	NULL
-	NULL
SS	NULL
Lat	NULL
_	NULL
}	NULL
<	NULL
-	NULL
SS	NULL
A	NULL
-	NULL
Â»	NULL
Â»	NULL
tual	NULL
hot	NULL
<	NULL
â¬-	NULL
Sp1+2	NULL
B	NULL
-	NULL
>	NULL
Â»	NULL
dome	NULL
|	NULL
bod	NULL
<	NULL
-	NULL
Sp1/Sp3	NULL
B	NULL
-	NULL
Â»	NULL
dung	NULL
bs	NULL
toad	NULL
i+	NULL
tual	NULL
WB	NULL
=	NULL
<	NULL
-	NULL
spusps	NULL
c	NULL
<	NULL
-	NULL
Ku	NULL
Lal	NULL
C	NULL
-	NULL
>	NULL
<	NULL
-	NULL
Ku	NULL
D	NULL
-	NULL
>	NULL
-	NULL
<	NULL
-	NULL
Sp3	NULL
D	NULL
-	NULL
Â»	NULL
bowt	NULL
tnad	NULL
~*	NULL
tut	NULL
tot	NULL
<	NULL
-	NULL
Sp3/Z	NULL
<	NULL
-E	NULL
-	NULL
Â»	NULL
was	NULL
Guay	NULL
mes	NULL
ned	NULL
thst	NULL
NS	NULL
C	NULL
lims	NULL
kaas	NULL
haat	NULL
kash	NULL
wan	NULL
_	NULL
Â«	NULL
<	NULL
-	NULL
NS	NULL
F	NULL
-	NULL
#	NULL
F	NULL
-	NULL
Â»	NULL
Â«	NULL
o	NULL
#	NULL
o	NULL
coe	NULL
-	NULL
>	NULL
CW	NULL
lg	NULL
ings	NULL
ames	NULL
cae	NULL
aus	NULL
tah	NULL
th	NULL
P	NULL
~-	NULL
.	NULL

>	NULL
Repa	NULL
um	NULL
us	NULL
up	NULL
us	NULL
us	NULL
5	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1	NULL
2	NULL
1	NULL
2	NULL
3	NULL
-	NULL
4	NULL
11	NULL
3	NULL
0	NULL
400	NULL
5006007	NULL
competitor	NULL
:	NULL
-	NULL
R	NULL
P	NULL
&	NULL
+o	NULL
w	NULL
64/35	NULL
ZIIB	NULL
_.	NULL
antiserum	NULL
:	NULL
.	NULL

-	NULL
~	NULL
__\	NULL
h	NULL
SPN	NULL
SP3	NULL
SpI	NULL
_	NULL
baie	NULL
ron	NULL
e	NULL
antiserum	NULL
:	NULL
-	NULL
-	NULL
-	NULL
Sp3	NULL
-	NULL
Sp3	NULL
extract	NULL
--	NULL
U	NULL
org	NULL
extract	NULL
:	NULL
-	NULL
U	NULL
-J	NULL
Â»	NULL
RZ	NULL
A	NULL
-	NULL
>	NULL
â	NULL
n	NULL
â	NULL
u	NULL
goos	NULL
Igguz	NULL
B	NULL
-	NULL
Â»	NULL
.-	NULL
luath	NULL
-	NULL
...	NULL
Said	NULL
w	NULL
-	NULL
<	NULL
Sp1/Sp3	NULL
C	NULL
-	NULL
>	NULL
td	NULL
<	NULL
-	NULL
Ku	NULL
Dp	NULL
-	NULL
Â»	NULL
Wl	NULL
blt	NULL
WW	NULL
bog	NULL
buh	NULL
tort	NULL
bout	NULL
toed	NULL
<	NULL
-	NULL
Sp3/Z	NULL
E	NULL
-	NULL
Â»	NULL
Ails	NULL
wath	NULL
\euch	NULL
nse	NULL
|	NULL
Whe	NULL
-	NULL
<	NULL
NS	NULL
F	NULL
-	NULL
>	NULL
probe	NULL
-	NULL
Â»	NULL
h.	NULL
..	NULL
â	NULL
M	NULL
1	NULL
2	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11Â°	NULL
12	NULL
3	NULL
13	NULL
14	NULL
15	NULL
competitor	NULL
:	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
Sp1	NULL
RRE	NULL
-	NULL
-	NULL
-	NULL
-	NULL
Sp1	NULL
ZIiIIB	NULL
RRE	NULL
antiserum	NULL
:	NULL
-	NULL
-	NULL
Z	NULL
Sp1	NULL
Spt	NULL
-	NULL
-	NULL
-	NULL
-_	NULL
Z	NULL
Sp1	NULL
Spit	NULL
o-	NULL
-	NULL
Sp3	NULL
Sp3	NULL
extract	NULL
:	NULL
-	NULL
4	NULL
U	NULL
it	NULL
RZ	NULL
1	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Identification	NULL
of	NULL
proteins	NULL
binding	NULL
to	NULL
Rp	NULL
-64/-28	NULL
by	NULL
antibody	NULL
supershifts	NULL
and	NULL
by	NULL
oligonucleotide	NULL
competition	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Identification	NULL
of	NULL
proteins	NULL
in	NULL
uninduced	NULL
(	NULL
U	NULL
)	NULL
C116	NULL
extracts	NULL
binding	NULL
to	NULL
the	NULL
Rp	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Complex	NULL
designation	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
(	NULL
B	NULL
to	NULL
F	NULL
)	NULL
;	NULL
identified	NULL
proteins	NULL
are	NULL
on	NULL
the	NULL
right	NULL
(	NULL
SS	NULL
,	NULL
supershifted	NULL
bands	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
probe	NULL
alone	NULL
;	NULL
lanes	NULL
2	NULL
to	NULL
7	NULL
,	NULL
7	NULL
jg	NULL
of	NULL
cell	NULL
extract	NULL
;	NULL
lanes	NULL
3	NULL
to	NULL
7	NULL
contain	NULL
antiserum	NULL
to	NULL
the	NULL
indicated	NULL
proteins	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sp1	NULL
and	NULL
ZEBRA	NULL
occupy	NULL
Rp	NULL
-64/-28	NULL
together	NULL
in	NULL
complex	NULL
A.	NULL
Extracts	NULL
of	NULL
uninduced	NULL
cells	NULL
(	NULL
U	NULL
)	NULL
and	NULL
of	NULL
C116	NULL
cells	NULL
transfected	NULL
with	NULL
ZEBRA	NULL
and	NULL
Rta	NULL
expression	NULL
vectors	NULL
(	NULL
RZ	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
the	NULL
indicated	NULL
antisera	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
5	NULL
and	NULL
10	NULL
to	NULL
12	NULL
)	NULL
or	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
the	NULL
indicated	NULL
unlabeled	NULL
competitor	NULL
DNA	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
8	NULL
and	NULL
14	NULL
to	NULL
16	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Competition	NULL
and	NULL
supershift	NULL
analysis	NULL
identify	NULL
ZEBRA	NULL
in	NULL
complex	NULL
D1	NULL
in	NULL
extracts	NULL
of	NULL
induced	NULL
C116	NULL
cells	NULL
.	NULL

Uninduced	NULL
(	NULL
U	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
Rta	NULL
and	NULL
ZEBRA-transfected	NULL
(	NULL
RZ	NULL
,	NULL
lanes	NULL
4	NULL
to	NULL
11	NULL
)	NULL
C16	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
Rp	NULL
probe	NULL
and	NULL
Sp3	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
to	NULL
10	NULL
)	NULL
and	NULL
ZEBRA	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
antisera	NULL
.	NULL

Binding	NULL
reactions	NULL
in	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
also	NULL
contained	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
the	NULL
indicated	NULL
unlabeled	NULL
competitor	NULL
DNA	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
9	NULL
contained	NULL
Rp	NULL
-64/-28	NULL
,	NULL
-58/-28	NULL
,	NULL
-64/-35	NULL
,	NULL
and	NULL
-58/-35	NULL
,	NULL
respectively	NULL
;	NULL
lane	NULL
10	NULL
,	NULL
ZRE	NULL
ZIIIB	NULL
)	NULL
.	NULL

5246	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
B	NULL
-	NULL
>	NULL
C	NULL
-	NULL
>	NULL
Da	NULL
Â»	NULL
E	NULL
-	NULL
>	NULL
en	NULL
won	NULL
F	NULL
-	NULL
>	NULL
meme	NULL
probe	NULL
-	NULL
Â»	NULL
â	NULL
dbuigo	NULL
ui	NULL
p-	NULL
-=-	NULL
F	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
competitor	NULL
:	NULL
-	NULL
-Al	NULL
-	NULL
_-wt	NULL
wt	NULL
extract	NULL
:	NULL
i-	NULL
_	NULL
U	NULL
--	NULL
A	NULL
--	NULL
TB	NULL
--	NULL
i	NULL
AUTOSTIMULATION	NULL
OF	NULL
EBV	NULL
BRLFI	NULL
PROMOTER	NULL
-	NULL
5247	NULL
<	NULL
-	NULL
Sp1+2	NULL
'~	NULL
u	NULL
u	NULL
#	NULL
-	NULL
<	NULL
<	NULL
-	NULL
Sp1/Sp3	NULL
jos	NULL
Wes	NULL
ee	NULL
``	NULL
-	NULL
<	NULL
-Sp3	NULL
-	NULL
<	NULL
-	NULL
NS	NULL
-m	NULL
-	NULL
\	NULL
wt	NULL
CCTA	NULL
ke-	NULL
_	NULL
U	NULL
_	NULL
TB	NULL
TB	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

EMSA	NULL
patterns	NULL
on	NULL
mutant	NULL
oligonucleotides	NULL
that	NULL
decrease	NULL
or	NULL
enhance	NULL
the	NULL
response	NULL
of	NULL
Rp	NULL
to	NULL
Rta	NULL
.	NULL

Uninduced	NULL
(	NULL
U	NULL
)	NULL
and	NULL
chemically	NULL
induced	NULL
(	NULL
TB	NULL
)	NULL
C116	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
mutant	NULL
oligonucleotide	NULL
probes	NULL
AT	NULL
,	NULL
which	NULL
decreases	NULL
the	NULL
response	NULL
to	NULL
Rta	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
CCTA	NULL
,	NULL
which	NULL
increases	NULL
the	NULL
response	NULL
to	NULL
Rta	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
the	NULL
reaction	NULL
also	NULL
included	NULL
a	NULL
100-	NULL
or	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
mutant	NULL
oligonucleotide	NULL
.	NULL

Complex	NULL
designation	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
(	NULL
B	NULL
to	NULL
F	NULL
)	NULL
,	NULL
identified	NULL
proteins	NULL
on	NULL
the	NULL
right	NULL
(	NULL
SS	NULL
,	NULL
supershifted	NULL
bands	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Lane	NULL
1	NULL
,	NULL
probe	NULL
alone	NULL
;	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
,	NULL
uninduced	NULL
cell	NULL
extract	NULL
;	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
,	NULL
TPA	NULL
and	NULL
sodium	NULL
butyrate-induced	NULL
cell	NULL
extracts	NULL
(	NULL
TB	NULL
)	NULL
.	NULL

Rp	NULL
-64/-28	NULL
was	NULL
used	NULL
as	NULL
the	NULL
unlabeled	NULL
competitor	NULL
at	NULL
100-	NULL
and	NULL
500-fold	NULL
excess	NULL
in	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Lane	NULL
1	NULL
,	NULL
probe	NULL
alone	NULL
;	NULL
lanes	NULL
2	NULL
to	NULL
6	NULL
,	NULL
uninduced	NULL
cell	NULL
extract	NULL
;	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
,	NULL
TPA	NULL
and	NULL
sodium	NULL
butyrate-induced	NULL
cell	NULL
extracts	NULL
.	NULL

Rp	NULL
-64/-28	NULL
was	NULL
used	NULL
as	NULL
the	NULL
unlabeled	NULL
competitor	NULL
in	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
9	NULL
;	NULL
Rp	NULL
-64/-28	NULL
CCTA	NULL
was	NULL
used	NULL
in	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
.	NULL

Sp3	NULL
,	NULL
since	NULL
the	NULL
Spl	NULL
oligonucleotide	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
its	NULL
binding	NULL
.	NULL

Complex	NULL
D	NULL
was	NULL
renamed	NULL
D	NULL
,	NULL
,	NULL
,	NULL
because	NULL
it	NULL
is	NULL
composed	NULL
of	NULL
at	NULL
least	NULL
two	NULL
complexes	NULL
with	NULL
similar	NULL
electrophoretic	NULL
mobili-ties	NULL
in	NULL
induced	NULL
C6	NULL
extracts	NULL
.	NULL

The	NULL
slightly	NULL
slower-migrating	NULL
portion	NULL
of	NULL
complex	NULL
D	NULL
(	NULL
D	NULL
;	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
contain	NULL
ZEBRA	NULL
by	NULL
means	NULL
of	NULL
oligonucleotide	NULL
competition	NULL
and	NULL
antibody	NULL
supershift	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
wild-type	NULL
Rp	NULL
-64/-28	NULL
37-mer	NULL
unlabeled	NULL
oligonucleotide	NULL
completed	NULL
for	NULL
this	NULL
binding	NULL
activity	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
truncated	NULL
version	NULL
of	NULL
the	NULL
wild-type	NULL
Rp	NULL
fragment	NULL
24	NULL
nucleotides	NULL
in	NULL
length	NULL
(	NULL
-58/-35	NULL
)	NULL
,	NULL
which	NULL
does	NULL
not	NULL
include	NULL
the	NULL
ZRE	NULL
,	NULL
competed	NULL
for	NULL
Sp1	NULL
and	NULL
Sp3	NULL
binding	NULL
in	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
competitor	NULL
oligonucleotide	NULL
-64/-35	NULL
,	NULL
which	NULL
extends	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
37-mer	NULL
but	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
ZRE	NULL
,	NULL
similarly	NULL
failed	NULL
to	NULL
affect	NULL
formation	NULL
of	NULL
complex	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
oligonucleotide	NULL
-58/-28	NULL
,	NULL
extending	NULL
to	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
37-mer	NULL
,	NULL
which	NULL
encompasses	NULL
the	NULL
ZRE	NULL
,	NULL
competed	NULL
for	NULL
complex	NULL
D	NULL
;	NULL
to	NULL
the	NULL
same	NULL
degree	NULL
as	NULL
the	NULL
full-length	NULL
wild-type	NULL
-64/-28	NULL
fragment	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

A	NULL
ZIIIB	NULL
element	NULL
used	NULL
as	NULL
the	NULL
unlabeled	NULL
competitor	NULL
efficiently	NULL
eliminated	NULL
the	NULL
formation	NULL
of	NULL
any	NULL
D	NULL
,	NULL
complex	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

While	NULL
Â«	NULL
-Sp3	NULL
completely	NULL
supershifted	NULL
complex	NULL
D	NULL
;	NULL
,	NULL
formed	NULL
by	NULL
extracts	NULL
of	NULL
uninduced	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
the	NULL
more	NULL
slowly	NULL
migrating	NULL
D	NULL
,	NULL
complex	NULL
formed	NULL
by	NULL
induced	NULL
cell	NULL
extracts	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
antibody	NULL
to	NULL
Sp3	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
both	NULL
Â«	NULL
-Sp3	NULL
and	NULL
Â«	NULL
-ZEBRA	NULL
supershifted	NULL
D	NULL
;	NULL
as	NULL
well	NULL
as	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
is	NULL
consistent	NULL
with	NULL
reporter	NULL
mutagenesis	NULL
data	NULL
.	NULL

The	NULL
next	NULL
series	NULL
of	NULL
experiments	NULL
demonstrated	NULL
that	NULL
mutations	NULL
in	NULL
Rp	NULL
that	NULL
led	NULL
to	NULL
decreased	NULL
response	NULL
to	NULL
Rta	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
were	NULL
associated	NULL
with	NULL
decreased	NULL
binding	NULL
by	NULL
Spl	NULL
and	NULL
S	NULL
$	NULL
p3	NULL
.	NULL

The	NULL
mutation	NULL
(	NULL
AT	NULL
)	NULL
in	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
proximal	NULL
Sp1	NULL
site	NULL
of	NULL
Rp	NULL
that	NULL
severely	NULL
reduced	NULL
the	NULL
response	NULL
of	NULL
RpCAT	NULL
to	NULL
Rta	NULL
effectively	NULL
prevented	NULL
binding	NULL
of	NULL
Spl	NULL
and	NULL
Sp3	NULL
to	NULL
the	NULL
Rp	NULL
-64/-28	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

When	NULL
the	NULL
-64/-28	NULL
oligonucleotide	NULL
containing	NULL
this	NULL
mutation	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
complex	NULL
D	NULL
;	NULL
,	NULL
(	NULL
Sp3	NULL
)	NULL
was	NULL
no	NULL
longer	NULL
observed	NULL
,	NULL
and	NULL
only	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
complex	NULL
B	NULL
remained	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Use	NULL
of	NULL
the	NULL
Spl	NULL
AT	NULL
mutant	NULL
oligonucleotide	NULL
allowed	NULL
easy	NULL
visualization	NULL
of	NULL
the	NULL
D	NULL
,	NULL
complex	NULL
(	NULL
ZE-BRA	NULL
)	NULL
in	NULL
chemically	NULL
induced	NULL
cell	NULL
extracts	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
as	NULL
it	NULL
was	NULL
no	NULL
longer	NULL
masked	NULL
by	NULL
S	NULL
$	NULL
p3	NULL
in	NULL
complex	NULL
D	NULL
,	NULL
,	NULL
.	NULL

An	NULL
oligonucleotide	NULL
probe	NULL
with	NULL
the	NULL
CCTA	NULL
mutation	NULL
which	NULL
5248	NULL
RAGOCZY	NULL
AND	NULL
MILLER	NULL
eliminated	NULL
the	NULL
Zif268	NULL
site	NULL
and	NULL
resulted	NULL
in	NULL
enhanced	NULL
response	NULL
of	NULL
Rp	NULL
to	NULL
Rta	NULL
displayed	NULL
a	NULL
higher	NULL
affinity	NULL
for	NULL
Sp1	NULL
and	NULL
Sp3	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

While	NULL
this	NULL
probe	NULL
produced	NULL
a	NULL
pattern	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
that	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
the	NULL
wild-type	NULL
sequence	NULL
,	NULL
competition	NULL
experiments	NULL
showed	NULL
that	NULL
the	NULL
CCTA	NULL
mutant	NULL
oligonucleotide	NULL
competed	NULL
for	NULL
complexes	NULL
B	NULL
and	NULL
D	NULL
;	NULL
,	NULL
more	NULL
efficiently	NULL
than	NULL
did	NULL
the	NULL
wild-type	NULL
(	NULL
-64/-28	NULL
)	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
with	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

DISCUSSION	NULL
This	NULL
paper	NULL
presents	NULL
several	NULL
novel	NULL
insights	NULL
into	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Rta	NULL
protein	NULL
autostimulates	NULL
its	NULL
promoter	NULL
in	NULL
EBV-positive	NULL
B	NULL
cells	NULL
.	NULL

Reporter	NULL
assays	NULL
demonstrated	NULL
that	NULL
the	NULL
region	NULL
between	NULL
-299	NULL
and	NULL
+30	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
of	NULL
Rp	NULL
provides	NULL
all	NULL
sequences	NULL
necessary	NULL
for	NULL
strong	NULL
activation	NULL
by	NULL
Rta	NULL
.	NULL

Two	NULL
Sp1	NULL
sites	NULL
contained	NULL
within	NULL
this	NULL
region	NULL
proved	NULL
essential	NULL
for	NULL
Rta	NULL
to	NULL
activate	NULL
Rp	NULL
.	NULL

Other	NULL
cis	NULL
sequences	NULL
that	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
Rp	NULL
,	NULL
including	NULL
two	NULL
ZREs	NULL
and	NULL
two	NULL
Zif268	NULL
sites	NULL
,	NULL
were	NULL
dispensable	NULL
for	NULL
Rta-mediated	NULL
autostimulation	NULL
in	NULL
C116	NULL
cells	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
determined	NULL
that	NULL
Sp1	NULL
and	NULL
Sp3	NULL
were	NULL
the	NULL
principal	NULL
factors	NULL
binding	NULL
a	NULL
37-bp	NULL
Rp	NULL
fragment	NULL
in	NULL
extracts	NULL
of	NULL
both	NULL
uninduced	NULL
and	NULL
induced	NULL
C116	NULL
cells	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
Sp1	NULL
and	NULL
Sp3	NULL
to	NULL
the	NULL
probe	NULL
correlated	NULL
with	NULL
the	NULL
reporter	NULL
activities	NULL
in	NULL
the	NULL
mutagenesis	NULL
study	NULL
,	NULL
establishing	NULL
a	NULL
direct	NULL
link	NULL
between	NULL
transcriptional	NULL
activation	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
Spl	NULL
and/or	NULL
Sp3	NULL
.	NULL

ZEBRA	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
Rp	NULL
oligonucleotide	NULL
in	NULL
induced	NULL
cell	NULL
extracts	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
may	NULL
stimulate	NULL
the	NULL
promoter	NULL
in	NULL
conjunction	NULL
with	NULL
Spl	NULL
.	NULL

cis-active	NULL
elements	NULL
mediating	NULL
activation	NULL
of	NULL
Rp	NULL
by	NULL
Rta	NULL
.	NULL

Mutagenesis	NULL
in	NULL
the	NULL
region	NULL
5	NULL
'	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
demonstrated	NULL
that	NULL
only	NULL
the	NULL
two	NULL
Sp1	NULL
sites	NULL
were	NULL
crucial	NULL
for	NULL
autostimulation	NULL
by	NULL
Rta	NULL
.	NULL

Mutations	NULL
eliminating	NULL
either	NULL
one	NULL
or	NULL
both	NULL
of	NULL
these	NULL
sites	NULL
reduced	NULL
Rp	NULL
activity	NULL
between	NULL
three-	NULL
and	NULL
eightfold	NULL
relative	NULL
to	NULL
the	NULL
wild-type	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

While	NULL
Zalani	NULL
et	NULL
al	NULL
.	NULL

had	NULL
previously	NULL
shown	NULL
that	NULL
Sp1	NULL
activates	NULL
Rp	NULL
in	NULL
Drosophila	NULL
SL2	NULL
cells	NULL
and	NULL
implicated	NULL
the	NULL
Sp1	NULL
sites	NULL
in	NULL
the	NULL
constitutive	NULL
Rp	NULL
activity	NULL
in	NULL
epithelial	NULL
cells	NULL
(	NULL
86	NULL
)	NULL
,	NULL
here	NULL
we	NULL
now	NULL
assign	NULL
these	NULL
response	NULL
elements	NULL
a	NULL
role	NULL
in	NULL
the	NULL
indirect	NULL
activation	NULL
of	NULL
Rp	NULL
by	NULL
Rta	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Although	NULL
Zalani	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
that	NULL
Zif268	NULL
could	NULL
modestly	NULL
stimulate	NULL
Rp	NULL
in	NULL
the	NULL
D98/HE-R-1	NULL
fusion	NULL
epithelial	NULL
cell	NULL
line	NULL
(	NULL
85	NULL
)	NULL
,	NULL
we	NULL
found	NULL
no	NULL
evidence	NULL
that	NULL
Zif268	NULL
contributes	NULL
positively	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
Rp	NULL
by	NULL
Rta	NULL
in	NULL
C116	NULL
cells	NULL
.	NULL

Mutations	NULL
of	NULL
either	NULL
Zif268	NULL
site	NULL
did	NULL
not	NULL
reduce	NULL
Rta-mediated	NULL
Rp	NULL
activity	NULL
,	NULL
provided	NULL
that	NULL
the	NULL
proximal	NULL
overlapping	NULL
Sp1	NULL
site	NULL
remained	NULL
intact	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
correlation	NULL
between	NULL
activation	NULL
of	NULL
Zif268	NULL
expression	NULL
and	NULL
induction	NULL
of	NULL
the	NULL
viral	NULL
lytic	NULL
cycle	NULL
in	NULL
CH6	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
ZREs	NULL
did	NULL
not	NULL
impair	NULL
the	NULL
ability	NULL
of	NULL
Rta	NULL
to	NULL
autostimulate	NULL
its	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
indirect	NULL
autostimulatory	NULL
pathway	NULL
at	NULL
Rp	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
ZEBRA	NULL
's	NULL
binding	NULL
to	NULL
the	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
ZEBRA	NULL
is	NULL
likely	NULL
to	NULL
directly	NULL
stimulate	NULL
this	NULL
promoter	NULL
by	NULL
binding	NULL
to	NULL
its	NULL
cognate	NULL
response	NULL
elements	NULL
.	NULL

Therefore	NULL
,	NULL
Rp	NULL
is	NULL
stimulated	NULL
by	NULL
a	NULL
complex	NULL
mechanism	NULL
involving	NULL
cellular	NULL
proteins	NULL
,	NULL
indirectly	NULL
by	NULL
Rta	NULL
and	NULL
directly	NULL
by	NULL
ZEBRA	NULL
.	NULL

Proteins	NULL
that	NULL
bind	NULL
the	NULL
Rta-responsive	NULL
region	NULL
of	NULL
Rp	NULL
.	NULL

Figure	NULL
9	NULL
summarizes	NULL
our	NULL
results	NULL
.	NULL

The	NULL
predominant	NULL
factors	NULL
binding	NULL
to	NULL
Rp	NULL
-64/-28	NULL
in	NULL
uninduced	NULL
and	NULL
induced	NULL
C116	NULL
cell	NULL
extracts	NULL
were	NULL
Sp1	NULL
and	NULL
Sp3	NULL
.	NULL

ZEBRA	NULL
was	NULL
also	NULL
found	NULL
to	NULL
bind	NULL
the	NULL
Rp	NULL
fragment	NULL
,	NULL
J.	NULL
VirRou	NULL
.	NULL

Uninduced	NULL
|	NULL
Induced	NULL
Complex	NULL
A	NULL
64	NULL
-28	NULL
==	NULL
Complex	NULL
B4	NULL
84	NULL
-28	NULL
-	NULL
Complex	NULL
B	NULL
*	NULL
os	NULL
oF	NULL
|	NULL
+	NULL
Complex	NULL
D	NULL
;	NULL
-64	NULL
-28	NULL
E	NULL
+	NULL
Complex	NULL
D.	NULL
64	NULL
2	NULL
ZINA	NULL
2s	NULL
0	NULL
fo	NULL
|	NULL
f	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Summary	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
identified	NULL
in	NULL
EMSA	NULL
experiments	NULL
.	NULL

The	NULL
oligonucleotide	NULL
probe	NULL
Rp	NULL
-64/-28	NULL
is	NULL
illustrated	NULL
with	NULL
the	NULL
overlapping	NULL
Zif268	NULL
and	NULL
Spl	NULL
binding	NULL
sites	NULL
and	NULL
the	NULL
ZRE	NULL
(	NULL
ZIIIA	NULL
)	NULL
.	NULL

Ovals	NULL
represent	NULL
the	NULL
proteins	NULL
identified	NULL
in	NULL
complexes	NULL
.	NULL

Complexes	NULL
A	NULL
and	NULL
D	NULL
,	NULL
were	NULL
identified	NULL
only	NULL
in	NULL
extracts	NULL
of	NULL
induced	NULL
cells	NULL
;	NULL
complexes	NULL
B	NULL
,	NULL
,	NULL
,	NULL
and	NULL
D	NULL
;	NULL
were	NULL
found	NULL
in	NULL
both	NULL
uninduced	NULL
and	NULL
induced	NULL
cell	NULL
extracts	NULL
.	NULL

either	NULL
alone	NULL
or	NULL
in	NULL
conjunction	NULL
with	NULL
Sp1	NULL
,	NULL
forming	NULL
a	NULL
larger	NULL
complex	NULL
of	NULL
slow	NULL
mobility	NULL
.	NULL

Although	NULL
Sp1	NULL
and	NULL
Sp3	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
recognition	NULL
sequences	NULL
,	NULL
only	NULL
Sp1	NULL
and	NULL
the	NULL
smaller	NULL
(	NULL
70	NULL
to	NULL
80	NULL
kDa	NULL
)	NULL
isoform	NULL
of	NULL
Sp3	NULL
were	NULL
found	NULL
binding	NULL
the	NULL
same	NULL
oligonucleotide	NULL
together	NULL
with	NULL
ZEBRA	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
ZEBRA	NULL
interferes	NULL
sterically	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
large	NULL
Sp3	NULL
isoform	NULL
,	NULL
but	NULL
not	NULL
Sp1	NULL
.	NULL

Conversely	NULL
,	NULL
the	NULL
large	NULL
(	NULL
110	NULL
to	NULL
115	NULL
kDa	NULL
)	NULL
isoform	NULL
of	NULL
Sp3	NULL
may	NULL
prevent	NULL
ZEBRA	NULL
from	NULL
binding	NULL
the	NULL
oligonucleotide	NULL
simul-taneously	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
ZEBRA	NULL
coincides	NULL
with	NULL
a	NULL
disappearance	NULL
of	NULL
functionally	NULL
competent	NULL
Sp3	NULL
.	NULL

Overall	NULL
,	NULL
these	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
Spl	NULL
and/or	NULL
Sp3	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
Rp	NULL
.	NULL

The	NULL
Sp1	NULL
sites	NULL
were	NULL
crucial	NULL
for	NULL
Rta-induced	NULL
promoter	NULL
activity	NULL
;	NULL
moreover	NULL
,	NULL
Spl	NULL
and	NULL
Sp3	NULL
were	NULL
the	NULL
most	NULL
prominent	NULL
factors	NULL
binding	NULL
the	NULL
proximal	NULL
Sp1	NULL
site	NULL
.	NULL

Functional	NULL
analysis	NULL
by	NULL
mutagenesis	NULL
of	NULL
cis-active	NULL
sites	NULL
strongly	NULL
correlated	NULL
with	NULL
experiments	NULL
examining	NULL
protein-DNA	NULL
interac-tions	NULL
.	NULL

A	NULL
mutation	NULL
causing	NULL
severe	NULL
reductions	NULL
in	NULL
promoter	NULL
activity	NULL
was	NULL
associated	NULL
with	NULL
absence	NULL
of	NULL
Spl	NULL
and	NULL
Sp3	NULL
binding	NULL
to	NULL
a	NULL
probe	NULL
bearing	NULL
the	NULL
same	NULL
mutation	NULL
.	NULL

Conversely	NULL
,	NULL
a	NULL
gain-of-func-tion	NULL
mutation	NULL
in	NULL
the	NULL
reporter	NULL
assay	NULL
also	NULL
resulted	NULL
in	NULL
increased	NULL
Sp1	NULL
and	NULL
Sp3	NULL
binding	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
.	NULL

Functional	NULL
role	NULL
of	NULL
Sp1	NULL
and	NULL
Sp3	NULL
in	NULL
regulation	NULL
of	NULL
Rp	NULL
.	NULL

How	NULL
can	NULL
the	NULL
ubiquitous	NULL
nature	NULL
of	NULL
Sp1	NULL
and	NULL
Sp3	NULL
in	NULL
uninduced	NULL
and	NULL
induced	NULL
cell	NULL
extracts	NULL
be	NULL
reconciled	NULL
with	NULL
their	NULL
involvement	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
promoter	NULL
activated	NULL
only	NULL
upon	NULL
the	NULL
switch	NULL
from	NULL
viral	NULL
latency	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
?	NULL

Sp1	NULL
is	NULL
generally	NULL
considered	NULL
an	NULL
activator	NULL
of	NULL
housekeeping	NULL
genes	NULL
and	NULL
cell	NULL
cycle	NULL
regulatory	NULL
genes	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
prevention	NULL
Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
of	NULL
silencing	NULL
by	NULL
the	NULL
methylation	NULL
of	NULL
CpG	NULL
islands	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
references	NULL
10	NULL
,	NULL
49	NULL
,	NULL
and	NULL
75	NULL
)	NULL
.	NULL

Sp1	NULL
is	NULL
under	NULL
posttranslational	NULL
regulation	NULL
by	NULL
several	NULL
kinases	NULL
and	NULL
phosphatases	NULL
in	NULL
response	NULL
to	NULL
different	NULL
stimuli	NULL
and	NULL
signaling	NULL
cascades	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
32	NULL
,	NULL
40	NULL
,	NULL
54	NULL
,	NULL
66	NULL
,	NULL
68	NULL
,	NULL
87	NULL
)	NULL
.	NULL

These	NULL
modifications	NULL
can	NULL
result	NULL
in	NULL
altered	NULL
DNA-binding	NULL
affinity	NULL
and	NULL
transactivation	NULL
potential	NULL
.	NULL

Consequently	NULL
,	NULL
despite	NULL
its	NULL
ubiquitous	NULL
nature	NULL
,	NULL
Sp1	NULL
is	NULL
under	NULL
specific	NULL
regulation	NULL
and	NULL
may	NULL
be	NULL
inhibited	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
Rp	NULL
during	NULL
viral	NULL
latency	NULL
.	NULL

While	NULL
Sp1	NULL
and	NULL
Sp3	NULL
are	NULL
homologous	NULL
proteins	NULL
that	NULL
have	NULL
the	NULL
same	NULL
DNA-binding	NULL
specificities	NULL
,	NULL
Sp3	NULL
exhibits	NULL
more	NULL
complex	NULL
behavior	NULL
than	NULL
Sp1	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Although	NULL
Sp3	NULL
activates	NULL
transcription	NULL
under	NULL
some	NULL
circumstances	NULL
(	NULL
44	NULL
,	NULL
45	NULL
,	NULL
78	NULL
)	NULL
,	NULL
more	NULL
often	NULL
it	NULL
antagonizes	NULL
Sp1-mediated	NULL
activation	NULL
(	NULL
24	NULL
,	NULL
25	NULL
,	NULL
50-52	NULL
)	NULL
.	NULL

Alterations	NULL
in	NULL
the	NULL
Sp1	NULL
to	NULL
Sp3	NULL
ratio	NULL
may	NULL
lead	NULL
to	NULL
activation	NULL
or	NULL
repression	NULL
of	NULL
individual	NULL
promoters	NULL
(	NULL
3	NULL
,	NULL
12	NULL
,	NULL
26	NULL
,	NULL
41	NULL
,	NULL
75	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
papillomavirus	NULL
(	NULL
HPV	NULL
)	NULL
gene	NULL
expression	NULL
reveals	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
Sp1/Sp3	NULL
ratio	NULL
in	NULL
different	NULL
cell	NULL
backgrounds	NULL
(	NULL
3	NULL
)	NULL
.	NULL

While	NULL
HPV	NULL
may	NULL
infect	NULL
many	NULL
different	NULL
types	NULL
of	NULL
cells	NULL
,	NULL
viral	NULL
gene	NULL
expression	NULL
is	NULL
confined	NULL
to	NULL
epithelial	NULL
cells	NULL
(	NULL
11	NULL
,	NULL
19	NULL
,	NULL
60	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Apt	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
that	NULL
Sp1	NULL
and	NULL
Sp3	NULL
have	NULL
opposing	NULL
effects	NULL
on	NULL
HPV	NULL
gene	NULL
expression	NULL
.	NULL

Several	NULL
epithelial	NULL
cell	NULL
lines	NULL
supporting	NULL
HPV	NULL
gene	NULL
expression	NULL
exhibited	NULL
higher	NULL
Sp1/Sp3	NULL
ratios	NULL
than	NULL
other	NULL
nonpermissive	NULL
tissues	NULL
.	NULL

This	NULL
observation	NULL
led	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
a	NULL
high	NULL
Sp1/Sp3	NULL
ratio	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
cell	NULL
type-specific	NULL
expression	NULL
of	NULL
HPV	NULL
genes	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
through	NULL
the	NULL
Sp1/Sp3	NULL
ratio	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
control	NULL
of	NULL
the	NULL
EBV	NULL
Rp	NULL
promoter	NULL
.	NULL

RpCAT	NULL
reporters	NULL
manifest	NULL
higher	NULL
constitutive	NULL
activity	NULL
in	NULL
epithelial	NULL
cells	NULL
than	NULL
in	NULL
lymphocytes	NULL
(	NULL
18	NULL
,	NULL
70	NULL
,	NULL
86	NULL
)	NULL
.	NULL

This	NULL
constitutive	NULL
activity	NULL
of	NULL
RpCAT	NULL
in	NULL
epithelial	NULL
cells	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
depend	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
proximal	NULL
Sp1	NULL
site	NULL
(	NULL
3	NULL
,	NULL
86	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
model	NULL
of	NULL
Apt	NULL
et	NULL
al	NULL
.	NULL

suggesting	NULL
that	NULL
a	NULL
high	NULL
Sp1/Sp3	NULL
ratio	NULL
favors	NULL
transcriptional	NULL
activation	NULL
by	NULL
Spl	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

We	NULL
therefore	NULL
propose	NULL
a	NULL
model	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
Rp	NULL
by	NULL
Rta	NULL
via	NULL
Sp1	NULL
and	NULL
Sp3	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

During	NULL
latency	NULL
,	NULL
the	NULL
promoter	NULL
is	NULL
silent	NULL
due	NULL
to	NULL
an	NULL
unfavorable	NULL
functional	NULL
ratio	NULL
of	NULL
Sp1	NULL
to	NULL
Sp3	NULL
in	NULL
the	NULL
cell	NULL
,	NULL
leaving	NULL
Sp3	NULL
to	NULL
repress	NULL
the	NULL
activation	NULL
of	NULL
Rp	NULL
.	NULL

This	NULL
may	NULL
be	NULL
achieved	NULL
either	NULL
by	NULL
an	NULL
enhanced	NULL
DNA-binding	NULL
affinity	NULL
of	NULL
Sp3	NULL
over	NULL
Sp1	NULL
due	NULL
to	NULL
protein	NULL
phosphorylation	NULL
or	NULL
by	NULL
differences	NULL
in	NULL
protein	NULL
concentration	NULL
.	NULL

An	NULL
inducing	NULL
stimulus	NULL
for	NULL
the	NULL
lytic	NULL
cycle	NULL
of	NULL
the	NULL
virus	NULL
may	NULL
then	NULL
reverse	NULL
the	NULL
ratio	NULL
of	NULL
Sp1	NULL
to	NULL
Sp3	NULL
,	NULL
shifting	NULL
it	NULL
in	NULL
favor	NULL
of	NULL
Sp1	NULL
.	NULL

This	NULL
effect	NULL
may	NULL
be	NULL
mimicked	NULL
by	NULL
expression	NULL
of	NULL
Rta	NULL
,	NULL
leading	NULL
to	NULL
autostimulation	NULL
of	NULL
Rp	NULL
.	NULL

There	NULL
are	NULL
several	NULL
ways	NULL
in	NULL
which	NULL
Rta	NULL
might	NULL
affect	NULL
the	NULL
amount	NULL
of	NULL
functional	NULL
Sp1	NULL
or	NULL
Sp3	NULL
.	NULL

Rta	NULL
could	NULL
directly	NULL
activate	NULL
expression	NULL
of	NULL
Sp1	NULL
or	NULL
repress	NULL
expression	NULL
of	NULL
Sp3	NULL
.	NULL

However	NULL
,	NULL
preliminary	NULL
data	NULL
from	NULL
immunoblots	NULL
do	NULL
not	NULL
suggest	NULL
an	NULL
alteration	NULL
in	NULL
Spl	NULL
or	NULL
Sp3	NULL
protein	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Rta	NULL
could	NULL
also	NULL
associate	NULL
with	NULL
$	NULL
p3	NULL
,	NULL
sequestering	NULL
it	NULL
from	NULL
the	NULL
promoter	NULL
.	NULL

A	NULL
direct	NULL
interaction	NULL
with	NULL
Sp1	NULL
is	NULL
less	NULL
likely	NULL
,	NULL
since	NULL
we	NULL
can	NULL
not	NULL
detect	NULL
a	NULL
DNA-protein	NULL
complex	NULL
that	NULL
contains	NULL
both	NULL
Sp1	NULL
and	NULL
Rta	NULL
in	NULL
our	NULL
gel	NULL
shift	NULL
analysis	NULL
.	NULL

Furthermore	NULL
,	NULL
Rta	NULL
could	NULL
feed	NULL
into	NULL
signal	NULL
transduction	NULL
pathways	NULL
leading	NULL
to	NULL
the	NULL
modification	NULL
of	NULL
either	NULL
Sp1	NULL
or	NULL
Sp3	NULL
.	NULL

The	NULL
gel	NULL
shift	NULL
analysis	NULL
did	NULL
not	NULL
reveal	NULL
a	NULL
change	NULL
in	NULL
abundance	NULL
of	NULL
Spl	NULL
or	NULL
Sp3	NULL
following	NULL
expression	NULL
of	NULL
Rta	NULL
.	NULL

Their	NULL
complex	NULL
intensities	NULL
were	NULL
similar	NULL
regardless	NULL
of	NULL
whether	NULL
the	NULL
binding	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
uninduced	NULL
or	NULL
induced	NULL
C16	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
any	NULL
subtle	NULL
change	NULL
in	NULL
complex	NULL
formation	NULL
using	NULL
induced	NULL
C116	NULL
cell	NULL
extracts	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
masked	NULL
by	NULL
an	NULL
abundance	NULL
AUTOSTIMULATION	NULL
OF	NULL
EBV	NULL
BRLFI	NULL
PROMOTER	NULL
-	NULL
5249	NULL
A	NULL
\	NULL
@	NULL
*	NULL
>	NULL
BX	NULL
``	NULL
hur	NULL
y	NULL
``	NULL
Ty	NULL
p	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Model	NULL
for	NULL
autoactivation	NULL
of	NULL
Rp	NULL
by	NULL
Rta	NULL
,	NULL
Spl	NULL
,	NULL
and	NULL
Sp3	NULL
.	NULL

Schematic	NULL
illustration	NULL
of	NULL
the	NULL
scenario	NULL
explaining	NULL
how	NULL
the	NULL
expression	NULL
of	NULL
Rta	NULL
could	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
Rp	NULL
through	NULL
Sp1	NULL
in	NULL
a	NULL
permissive	NULL
B-cell	NULL
background	NULL
such	NULL
as	NULL
C116	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Rp	NULL
is	NULL
shown	NULL
in	NULL
its	NULL
silent	NULL
form	NULL
during	NULL
latency	NULL
on	NULL
the	NULL
left	NULL
and	NULL
in	NULL
its	NULL
activated	NULL
form	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Ovals	NULL
represent	NULL
the	NULL
protein	NULL
factors	NULL
Sp1	NULL
,	NULL
Sp3	NULL
,	NULL
and	NULL
Rta	NULL
involved	NULL
in	NULL
the	NULL
repression	NULL
or	NULL
activation	NULL
processes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Potential	NULL
HDAC	NULL
repression	NULL
of	NULL
Rp	NULL
.	NULL

See	NULL
text	NULL
for	NULL
details	NULL
.	NULL

of	NULL
uninduced	NULL
cells	NULL
in	NULL
the	NULL
population	NULL
.	NULL

Chemical	NULL
treatment	NULL
induces	NULL
about	NULL
40	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
,	NULL
while	NULL
transfection	NULL
of	NULL
Rta	NULL
or	NULL
ZEBRA	NULL
expression	NULL
vectors	NULL
has	NULL
an	NULL
efficiency	NULL
of	NULL
approximately	NULL
1	NULL
%	NULL
.	NULL

Determination	NULL
of	NULL
changes	NULL
in	NULL
complex	NULL
abundance	NULL
thus	NULL
awaits	NULL
an	NULL
experimental	NULL
strategy	NULL
allowing	NULL
100	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
be	NULL
induced	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
report	NULL
,	NULL
Doetzlhofer	NULL
et	NULL
al	NULL
.	NULL

proposed	NULL
that	NULL
inhibition	NULL
of	NULL
activation	NULL
by	NULL
Sp1	NULL
could	NULL
result	NULL
from	NULL
an	NULL
association	NULL
with	NULL
members	NULL
of	NULL
the	NULL
histone	NULL
deacetylase	NULL
(	NULL
HDAC	NULL
)	NULL
family	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Not	NULL
only	NULL
could	NULL
HDAC1	NULL
prevent	NULL
Sp1	NULL
from	NULL
engaging	NULL
in	NULL
other	NULL
protein-protein	NULL
interactions	NULL
necessary	NULL
for	NULL
transcriptional	NULL
acti-vation	NULL
,	NULL
but	NULL
the	NULL
presence	NULL
of	NULL
HDAC1	NULL
could	NULL
also	NULL
stabilize	NULL
the	NULL
repressive	NULL
effect	NULL
of	NULL
higher-order	NULL
chromatin	NULL
structures	NULL
.	NULL

Trichostatin	NULL
A	NULL
,	NULL
an	NULL
HDAC	NULL
inhibitor	NULL
,	NULL
was	NULL
reported	NULL
to	NULL
relieve	NULL
this	NULL
repression	NULL
by	NULL
HDAC1	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Other	NULL
groups	NULL
have	NULL
also	NULL
reported	NULL
that	NULL
trichostatin	NULL
A	NULL
enhances	NULL
Spl-mediated	NULL
activity	NULL
and	NULL
that	NULL
this	NULL
process	NULL
requires	NULL
the	NULL
concomitant	NULL
expression	NULL
of	NULL
CBP/p300	NULL
,	NULL
a	NULL
histone	NULL
acetyltransferase	NULL
(	NULL
81	NULL
)	NULL
.	NULL

These	NULL
events	NULL
would	NULL
be	NULL
fully	NULL
consistent	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
EBV	NULL
lytic	NULL
cycle	NULL
that	NULL
is	NULL
observed	NULL
upon	NULL
treatment	NULL
of	NULL
C116	NULL
cells	NULL
with	NULL
trichostatin	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
cycle-regulated	NULL
transcription	NULL
factor	NULL
E2F1	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
autostimulation	NULL
of	NULL
Rp	NULL
by	NULL
Rta	NULL
.	NULL

E2F1	NULL
might	NULL
contribute	NULL
to	NULL
autoactivation	NULL
in	NULL
one	NULL
of	NULL
two	NULL
ways	NULL
,	NULL
by	NULL
binding	NULL
the	NULL
DNA	NULL
or	NULL
by	NULL
binding	NULL
to	NULL
Sp1	NULL
.	NULL

It	NULL
had	NULL
previously	NULL
been	NULL
suggested	NULL
that	NULL
Rta	NULL
activation	NULL
of	NULL
the	NULL
EBV	NULL
pol	NULL
!	NULL

gene	NULL
was	NULL
mediated	NULL
by	NULL
an	NULL
-like	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
DNA	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Although	NULL
Rp	NULL
contains	NULL
a	NULL
potential	NULL
binding	NULL
site	NULL
for	NULL
E2F1	NULL
,	NULL
partially	NULL
overlapping	NULL
the	NULL
proximal	NULL
Sp1	NULL
site	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
demonstrate	NULL
direct	NULL
binding	NULL
of	NULL
E2F1	NULL
to	NULL
Rp	NULL
in	NULL
our	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

All	NULL
members	NULL
of	NULL
5250	NULL
RAGOCZY	NULL
AND	NULL
MILLER	NULL
the	NULL
Sp1	NULL
protein	NULL
family	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
E2F1	NULL
(	NULL
67	NULL
)	NULL
,	NULL
and	NULL
genes	NULL
may	NULL
be	NULL
activated	NULL
syner-gistically	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
Sp1	NULL
and	NULL
E2F1	NULL
(	NULL
34	NULL
,	NULL
46	NULL
,	NULL
67	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
E2F1	NULL
and	NULL
HDACI	NULL
interact	NULL
with	NULL
the	NULL
same	NULL
surface	NULL
of	NULL
Sp1	NULL
.	NULL

In	NULL
their	NULL
competition	NULL
for	NULL
binding	NULL
to	NULL
Spl	NULL
,	NULL
E2F1	NULL
displaced	NULL
HDAC1	NULL
and	NULL
led	NULL
to	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
the	NULL
two	NULL
factors	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Either	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
E2F1	NULL
might	NULL
be	NULL
the	NULL
result	NULL
of	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
Rta	NULL
protein	NULL
to	NULL
interact	NULL
with	NULL
Rb	NULL
and	NULL
thereby	NULL
cause	NULL
the	NULL
release	NULL
of	NULL
E2F1	NULL
(	NULL
83	NULL
)	NULL
.	NULL

The	NULL
indirect	NULL
transactivation	NULL
mechanism	NULL
of	NULL
Rta	NULL
appears	NULL
to	NULL
differ	NULL
from	NULL
that	NULL
of	NULL
other	NULL
viral	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
VP16	NULL
protein	NULL
and	NULL
the	NULL
EBV	NULL
latency	NULL
protein	NULL
EBNAZ	NULL
.	NULL

Neither	NULL
of	NULL
these	NULL
proteins	NULL
binds	NULL
to	NULL
its	NULL
cognate	NULL
DNA	NULL
sequence	NULL
alone	NULL
,	NULL
but	NULL
requires	NULL
cellular	NULL
factors	NULL
for	NULL
recruitment	NULL
to	NULL
DNA	NULL
.	NULL

RBP-Jx	NULL
is	NULL
responsible	NULL
for	NULL
targeting	NULL
EBNAZ	NULL
to	NULL
DNA	NULL
(	NULL
29	NULL
,	NULL
33	NULL
,	NULL
79	NULL
)	NULL
,	NULL
while	NULL
in	NULL
the	NULL
case	NULL
of	NULL
VP16	NULL
,	NULL
two	NULL
proteins	NULL
,	NULL
Oct-1	NULL
and	NULL
host	NULL
cell	NULL
factor	NULL
,	NULL
are	NULL
required	NULL
(	NULL
17	NULL
,	NULL
35	NULL
,	NULL
39	NULL
,	NULL
53	NULL
,	NULL
74	NULL
,	NULL
82	NULL
)	NULL
.	NULL

However	NULL
,	NULL
both	NULL
EBNAZ	NULL
and	NULL
VP16	NULL
eventually	NULL
come	NULL
into	NULL
contact	NULL
with	NULL
the	NULL
DNA	NULL
as	NULL
the	NULL
result	NULL
of	NULL
tethering	NULL
by	NULL
cell	NULL
proteins	NULL
.	NULL

Rta	NULL
is	NULL
already	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
DNA	NULL
sequence	NULL
specifically	NULL
without	NULL
the	NULL
assistance	NULL
of	NULL
cofactors	NULL
in	NULL
vitro	NULL
(	NULL
21-23	NULL
)	NULL
.	NULL

This	NULL
property	NULL
presumably	NULL
forms	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
direct	NULL
activation	NULL
of	NULL
some	NULL
viral	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
BaRF1	NULL
,	NULL
by	NULL
Rta	NULL
(	NULL
64	NULL
)	NULL
.	NULL

The	NULL
indirect	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
Rta	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
may	NULL
not	NULL
involve	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
viral	NULL
promoter	NULL
,	NULL
since	NULL
we	NULL
and	NULL
others	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
detect	NULL
Rta	NULL
binding	NULL
to	NULL
Rp	NULL
probes	NULL
in	NULL
EMSA	NULL
(	NULL
86	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
Rta	NULL
to	NULL
activate	NULL
promoters	NULL
lacking	NULL
RREs	NULL
may	NULL
be	NULL
the	NULL
consequence	NULL
of	NULL
manipulation	NULL
of	NULL
cellular	NULL
signaling	NULL
pathways	NULL
.	NULL

This	NULL
capacity	NULL
may	NULL
or	NULL
may	NULL
not	NULL
involve	NULL
Rta	NULL
binding	NULL
to	NULL
the	NULL
promoters	NULL
of	NULL
cellular	NULL
genes	NULL
or	NULL
their	NULL
protein	NULL
products	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
this	NULL
indirect	NULL
function	NULL
of	NULL
Rta	NULL
may	NULL
evoke	NULL
a	NULL
change	NULL
in	NULL
the	NULL
effective	NULL
Spl	NULL
to	NULL
Sp3	NULL
ratio	NULL
,	NULL
leading	NULL
to	NULL
Spl-mediated	NULL
gene	NULL
activation	NULL
.	NULL

The	NULL
Rta	NULL
protein	NULL
thus	NULL
has	NULL
at	NULL
its	NULL
disposal	NULL
at	NULL
least	NULL
two	NULL
mechanisms	NULL
by	NULL
which	NULL
it	NULL
contributes	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
lytic	NULL
cascade	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
NIH	NULL
grants	NULL
CA16038	NULL
and	NULL
CA12055	NULL
to	NULL
G.M	NULL
.	NULL

We	NULL
thank	NULL
T.	NULL
Serio	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
S.	NULL
Ghosh	NULL
for	NULL
generous	NULL
use	NULL
of	NULL
laboratory	NULL
equipment	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ackerman	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
A.	NULL
G.	NULL
Minden	NULL
,	NULL
G.	NULL
T.	NULL
Williams	NULL
,	NULL
C.	NULL
Bobonis	NULL
,	NULL
and	NULL
C.	NULL
Y.	NULL
Yeung	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
significance	NULL
of	NULL
an	NULL
overlapping	NULL
consensus	NULL
binding	NULL
motif	NULL
for	NULL
Sp1	NULL
and	NULL
Zif268	NULL
in	NULL
the	NULL
murine	NULL
adenosine	NULL
deaminase	NULL
gene	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7523-7527	NULL
.	NULL

2	NULL
.	NULL

Alroy	NULL
,	NULL
L.	NULL
,	NULL
L.	NULL
Soussan	NULL
,	NULL
R.	NULL
Seger	NULL
,	NULL
and	NULL
Y.	NULL
Yarden	NULL
.	NULL

1999	NULL
.	NULL

Neu	NULL
differentiation	NULL
factor	NULL
stimulates	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
Sp1	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

19:1961-1972	NULL
.	NULL

3	NULL
.	NULL

Apt	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Watts	NULL
,	NULL
G.	NULL
Suske	NULL
,	NULL
and	NULL
H.	NULL
U.	NULL
Bernard	NULL
.	NULL

1996	NULL
.	NULL

High	NULL
Sp1/Sp3	NULL
ratios	NULL
in	NULL
epithelial	NULL
cells	NULL
during	NULL
epithelial	NULL
differentiation	NULL
and	NULL
cellular	NULL
transformation	NULL
correlate	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
HPV-16	NULL
promoter	NULL
.	NULL

Virology	NULL
224:281-291	NULL
.	NULL

4	NULL
.	NULL

Armstrong	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
D.	NULL
A.	NULL
Barry	NULL
,	NULL
R.	NULL
W.	NULL
Leggett	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
Mueller	NULL
.	NULL

1997	NULL
.	NULL

Casein	NULL
kinase	NULL
II-mediated	NULL
phosphorylation	NULL
of	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
Sp1	NULL
decreases	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:13489-13495	NULL
.	NULL

5	NULL
.	NULL

Babcock	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
L.	NULL
L.	NULL
Decker	NULL
,	NULL
M.	NULL
Volk	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Thorley-Lawson	NULL
.	NULL

1998	NULL
.	NULL

EBV	NULL
persistence	NULL
in	NULL
memory	NULL
B	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Immunity	NULL
9:395-404	NULL
.	NULL

6	NULL
.	NULL

Barroso	NULL
,	NULL
L	NULL
,	NULL
and	NULL
P.	NULL
Santisteban	NULL
.	NULL

1999	NULL
.	NULL

Insulin-induced	NULL
early	NULL
growth	NULL
response	NULL
gene	NULL
(	NULL
Egr-1	NULL
)	NULL
mediates	NULL
a	NULL
short	NULL
term	NULL
repression	NULL
of	NULL
rat	NULL
malic	NULL
enzyme	NULL
gene	NULL
transcription	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:17997-18004	NULL
.	NULL

7	NULL
.	NULL

Black	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
D.	NULL
Jensen	NULL
,	NULL
S.	NULL
Y.	NULL
Lin	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Azizkhan	NULL
.	NULL

1999	NULL
.	NULL

Growth/cell	NULL
cycle	NULL
regulation	NULL
of	NULL
Sp1	NULL
phosphorylation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:1207-1215	NULL
.	NULL

8	NULL
.	NULL

Blier	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
A.	NULL
J.	NULL
Griffith	NULL
,	NULL
J	NULL
.	NULL

Craft	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Hardin	NULL
.	NULL

1993	NULL
.	NULL

Binding	NULL
of	NULL
Ku	NULL
protein	NULL
to	NULL
DNA	NULL
:	NULL
measurement	NULL
of	NULL
affinity	NULL
for	NULL
ends	NULL
and	NULL
demonstration	NULL
of	NULL
binding	NULL
to	NULL
nicks	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:7594-7601	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

J.	NULL
Virou	NULL
.	NULL

.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
1976	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72:248-254	NULL
.	NULL

Brandeis	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Frank	NULL
,	NULL
I.	NULL
Keshet	NULL
,	NULL
Z.	NULL
Siegfried	NULL
,	NULL
M.	NULL
Mendelsohn	NULL
,	NULL
A.	NULL
Nemes	NULL
,	NULL
V.	NULL
Temper	NULL
,	NULL
A.	NULL
Razin	NULL
,	NULL
and	NULL
H.	NULL
Cedar	NULL
.	NULL

1994	NULL
.	NULL

Sp1	NULL
elements	NULL
protect	NULL
a	NULL
CpG	NULL
island	NULL
from	NULL
de	NULL
novo	NULL
methylation	NULL
.	NULL

Nature	NULL
371:435-438	NULL
.	NULL

Cripe	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
T.	NULL
H.	NULL
Haugen	NULL
,	NULL
J.	NULL
P.	NULL
Turk	NULL
,	NULL
F.	NULL
Tabatabai	NULL
,	NULL
P.	NULL
G.	NULL
d.	NULL
Schmid	NULL
,	NULL
M.	NULL
Durst	NULL
,	NULL
L.	NULL
Gissmann	NULL
,	NULL
A.	NULL
Roman	NULL
,	NULL
and	NULL
L.	NULL
P.	NULL
Turek	NULL
.	NULL

1987	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
papillomavirus-16	NULL
E6-E7	NULL
promoter	NULL
by	NULL
a	NULL
keratino-cyte-dependent	NULL
enhancer	NULL
,	NULL
and	NULL
by	NULL
viral	NULL
E2	NULL
trans-	NULL
activator	NULL
and	NULL
repressor	NULL
gene	NULL
products	NULL
:	NULL
implications	NULL
for	NULL
cervical	NULL
carcinogenesis	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:3745-3753	NULL
.	NULL

Discher	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
N.	NULL
H.	NULL
Bishopric	NULL
,	NULL
X.	NULL
Wu	NULL
,	NULL
C.	NULL
A.	NULL
Peterson	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Webster	NULL
.	NULL

1998	NULL
.	NULL

Hypoxia	NULL
regulates	NULL
beta-enolase	NULL
and	NULL
pyruvate	NULL
kinase-M	NULL
promoters	NULL
by	NULL
modulating	NULL
Sp1/Sp3	NULL
binding	NULL
to	NULL
a	NULL
conserved	NULL
GC	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:26087-26093	NULL
.	NULL

Doetzlhofer	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
Rotheneder	NULL
,	NULL
G.	NULL
Lagger	NULL
,	NULL
M.	NULL
Koranda	NULL
,	NULL
V.	NULL
Kurtey	NULL
,	NULL
G.	NULL
Brosch	NULL
,	NULL
E.	NULL
Wintersberger	NULL
,	NULL
and	NULL
C.	NULL
Seiser	NULL
.	NULL

1999	NULL
.	NULL

Histone	NULL
deacetylase	NULL
1	NULL
can	NULL
repress	NULL
transcription	NULL
by	NULL
binding	NULL
to	NULL
Sp1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

19:5504-5511	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Speck	NULL
.	NULL

1990	NULL
.	NULL

Autoregulation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
putative	NULL
lytic	NULL
switch	NULL
gene	NULL
BZLF1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1227-1232	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
A.	NULL
E.	NULL
Goldfeld	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Speck	NULL
.	NULL

1991	NULL
.	NULL

Efficient	NULL
transcription	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
Virus	NULL
immediate-carly	NULL
BZLF1	NULL
and	NULL
BRLF1	NULL
genes	NULL
requires	NULL
protein	NULL
synthesis	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:7073-7077	NULL
.	NULL

Francis	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1997	NULL
.	NULL

Alteration	NULL
of	NULL
a	NULL
single	NULL
serine	NULL
in	NULL
the	NULL
basic	NULL
domain	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
ZEBRA	NULL
protein	NULL
separates	NULL
its	NULL
functions	NULL
of	NULL
transcriptional	NULL
activation	NULL
and	NULL
disruption	NULL
of	NULL
latency	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:3054-3061	NULL
.	NULL

Gerster	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
herpesvirus	NULL
trans-activating	NULL
protein	NULL
interacts	NULL
with	NULL
transcription	NULL
factor	NULL
OTF-1	NULL
and	NULL
other	NULL
cellular	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:6347-6351	NULL
.	NULL

Glaser	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Vogel	NULL
,	NULL
H.	NULL
Wolf	NULL
,	NULL
and	NULL
H.	NULL
H.	NULL
Niller	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
viral	NULL
immediate	NULL
carly	NULL
BRLF1	NULL
promoter	NULL
through	NULL
a	NULL
distal	NULL
NF1	NULL
site	NULL
.	NULL

Arch	NULL
.	NULL

Virol	NULL
.	NULL

143:1967-1983	NULL
.	NULL

Gloss	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
U.	NULL
Bernard	NULL
,	NULL
K.	NULL
Seedorf	NULL
,	NULL
and	NULL
G.	NULL
Klock	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
upstream	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
human	NULL
papilloma	NULL
virus-16	NULL
contains	NULL
an	NULL
E2	NULL
protein-independent	NULL
enhancer	NULL
which	NULL
is	NULL
specific	NULL
for	NULL
cervical	NULL
carcinoma	NULL
cells	NULL
and	NULL
regulated	NULL
by	NULL
glucocorticoid	NULL
hormones	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:3735-3743	NULL
.	NULL

Gottlieb	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
S.	NULL
P.	NULL
Jackson	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
DNA-dependent	NULL
protein	NULL
kinase	NULL
:	NULL
requirement	NULL
for	NULL
DNA	NULL
ends	NULL
and	NULL
association	NULL
with	NULL
Ku	NULL
antigen	NULL
.	NULL

Cell	NULL
72131-142	NULL
.	NULL

Gruffat	NULL
,	NULL
H.	NULL
,	NULL
N.	NULL
Duran	NULL
,	NULL
M.	NULL
Buisson	NULL
,	NULL
F.	NULL
Wild	NULL
,	NULL
R.	NULL
Buckland	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
R-binding	NULL
site	NULL
mediating	NULL
the	NULL
R-induced	NULL
activation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BMLF1	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:46-52	NULL
.	NULL

Gruffat	NULL
,	NULL
H.	NULL
,	NULL
E.	NULL
Manet	NULL
,	NULL
A.	NULL
Rigolet	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
enhancer	NULL
factor	NULL
R	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
a	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
protein	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:6835-6843	NULL
.	NULL

Gruffat	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1994	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
DNA-binding	NULL
site	NULL
repertoire	NULL
for	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transcription	NULL
factor	NULL
R.	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:1172-1178	NULL
.	NULL

Hagen	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Dennig	NULL
,	NULL
A.	NULL
Preiss	NULL
,	NULL
M.	NULL
Beato	NULL
,	NULL
and	NULL
G.	NULL
Suske	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
analyses	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Sp4	NULL
reveal	NULL
properties	NULL
distinct	NULL
from	NULL
Sp1	NULL
and	NULL
Sp3	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:24989-24994	NULL
.	NULL

Hagen	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Muller	NULL
,	NULL
M.	NULL
Beato	NULL
,	NULL
and	NULL
G.	NULL
Suske	NULL
.	NULL

1994	NULL
.	NULL

Spl-mediated	NULL
transcriptional	NULL
activation	NULL
is	NULL
repressed	NULL
by	NULL
Sp3	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:3843-3851	NULL
.	NULL

Hata	NULL
,	NULL
Y.	NULL
,	NULL
E.	NULL
Duh	NULL
,	NULL
K.	NULL
Zhang	NULL
,	NULL
G.	NULL
S.	NULL
Robinson	NULL
,	NULL
and	NULL
L.	NULL
P.	NULL
Aiello	NULL
.	NULL

1998	NULL
.	NULL

Transcription	NULL
factors	NULL
Sp1	NULL
and	NULL
Sp3	NULL
alter	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
receptor	NULL
expression	NULL
through	NULL
a	NULL
novel	NULL
recognition	NULL
sequence	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273	NULL
:	NULL
19294-19303	NULL
.	NULL

Heinemeyer	NULL
,	NULL
T.	NULL
,	NULL
X.	NULL
Chen	NULL
,	NULL
H.	NULL
Karas	NULL
,	NULL
A.	NULL
E.	NULL
Kel	NULL
,	NULL
O.	NULL
V.	NULL
Kel	NULL
,	NULL
I.	NULL
Liebich	NULL
,	NULL
T.	NULL
Meinhardt	NULL
,	NULL
I.	NULL
Reuter	NULL
,	NULL
F.	NULL
Schacherer	NULL
,	NULL
and	NULL
E.	NULL
Wingender	NULL
.	NULL

1999	NULL
.	NULL

Expanding	NULL
the	NULL
TRANSFAC	NULL
database	NULL
towards	NULL
an	NULL
expert	NULL
system	NULL
of	NULL
regulatory	NULL
molecular	NULL
mechanisms	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

27:318-322	NULL
.	NULL

Heinemeyer	NULL
,	NULL
T.	NULL
,	NULL
E.	NULL
Wingender	NULL
,	NULL
I.	NULL
Reuter	NULL
,	NULL
H.	NULL
Hermjakob	NULL
,	NULL
A.	NULL
E.	NULL
Kel	NULL
,	NULL
O.	NULL
V.	NULL
Kel	NULL
,	NULL
E.	NULL
V.	NULL
Ignatieva	NULL
,	NULL
E.	NULL
A.	NULL
Ananko	NULL
,	NULL
O	NULL
.	NULL

A.	NULL
Podkolod	NULL
,	NULL
F.	NULL
A.	NULL
Kolpakoy	NULL
,	NULL
N.	NULL
L.	NULL
Podkoledny	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Kolchanov	NULL
.	NULL

1998	NULL
.	NULL

Databases	NULL
on	NULL
transcriptional	NULL
reg-ulation	NULL
:	NULL
TRANSFAC	NULL
,	NULL
TRRD	NULL
and	NULL
COMPEL	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

26:362-367	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
D.	NULL
Ling	NULL
,	NULL
S.	NULL
D.	NULL
Hayward	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Peterson	NULL
.	NULL

1994	NULL
.	NULL

Mediation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
EBNAZ	NULL
transactivation	NULL
by	NULL
recombination	NULL
signal-bind-ing	NULL
protein	NULL
J	NULL
kappa	NULL
.	NULL

Science	NULL
265:92-95	NULL
.	NULL

Heston	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Rabson	NULL
,	NULL
N.	NULL
Brown	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1982	NULL
.	NULL

New	NULL
Epstein-Barr	NULL
virus	NULL
variants	NULL
from	NULL
cellular	NULL
subclones	NULL
of	NULL
P3J-HR-1	NULL
Burkitt	NULL
lymphoma	NULL
.	NULL

Nature	NULL
295:160-163	NULL
.	NULL

Huang	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Y	NULL
.	NULL

Fan	NULL
,	NULL
Z.	NULL
Ni	NULL
,	NULL
D.	NULL
Mercola	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Adamson	NULL
.	NULL

1997	NULL
.	NULL

Reciprocal	NULL
modulation	NULL
between	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

66:489-499	NULL
.	NULL

Jackson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
J.	NULL
J.	NULL
MacDonald	NULL
,	NULL
S.	NULL
Lees-Miller	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1990	NULL
.	NULL

GC	NULL
box	NULL
binding	NULL
induces	NULL
phosphorylation	NULL
of	NULL
Sp1	NULL
by	NULL
a	NULL
DNA-dependent	NULL
protein	NULL
kinase	NULL
.	NULL

Cell	NULL
.	NULL

63:155-165	NULL
.	NULL

Johannsen	NULL
,	NULL
E.	NULL
,	NULL
E.	NULL
Koh	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
X.	NULL
Tong	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
S.	NULL
R.	NULL
Grossman	NULL
.	NULL

1995	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
protein	NULL
2	NULL
transactivation	NULL
of	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
promoter	NULL
is	NULL
mediated	NULL
by	NULL
J	NULL
kappa	NULL
and	NULL
PU.1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69	NULL
:	NULL
253-262	NULL
.	NULL

Vor	NULL
.	NULL

75	NULL
,	NULL
2001	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

Karlseder	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Rotheneder	NULL
,	NULL
and	NULL
E.	NULL
Wintersberger	NULL
.	NULL

1996	NULL
.	NULL

Interaction	NULL
of	NULL
Sp1	NULL
with	NULL
the	NULL
growth-	NULL
and	NULL
cell	NULL
cycle-regulated	NULL
transcription	NULL
factor	NULL
E2F	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1659-1667	NULL
.	NULL

Katan	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Haigh	NULL
,	NULL
C.	NULL
P.	NULL
Verrijzer	NULL
,	NULL
P.	NULL
C.	NULL
van	NULL
der	NULL
Vliet	NULL
,	NULL
and	NULL
P.	NULL
O'Hare	NULL
.	NULL

1990	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
cellular	NULL
factor	NULL
which	NULL
interacts	NULL
functionally	NULL
with	NULL
Oct-1	NULL
in	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
multicomponent	NULL
transcription	NULL
complex	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:6871-6880	NULL
.	NULL

Katz	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
R.	NULL
P.	NULL
Baumann	NULL
,	NULL
R.	NULL
Sun	NULL
,	NULL
J.	NULL
L.	NULL
Kolman	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1992	NULL
.	NULL

Viral	NULL
proteins	NULL
associated	NULL
with	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transactivator	NULL
,	NULL
ZEBRA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:378-382	NULL
.	NULL

Kennett	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
A.	NULL
J.	NULL
Udvadia	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Horowitz	NULL
.	NULL

1997	NULL
.	NULL

Sp3	NULL
encodes	NULL
multiple	NULL
proteins	NULL
that	NULL
differ	NULL
in	NULL
their	NULL
capacity	NULL
to	NULL
stimulate	NULL
or	NULL
repress	NULL
transcription	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

25:3110-3117	NULL
.	NULL

Kolman	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
J.	NULL
Countryman	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1996	NULL
.	NULL

Comparing	NULL
transcriptional	NULL
activation	NULL
and	NULL
autostimulation	NULL
by	NULL
ZEBRA	NULL
and	NULL
ZEBRA/c-Fos	NULL
chimeras	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:1493-1504	NULL
.	NULL

Kristie	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1990	NULL
.	NULL

Interactions	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
sub-domains	NULL
with	NULL
specific	NULL
DNA	NULL
sequences	NULL
and	NULL
with	NULL
the	NULL
HSV	NULL
alpha-trans-acti-vator	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:2383-2396	NULL
.	NULL

Kumar	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
A.	NULL
P.	NULL
Butler	NULL
.	NULL

1998	NULL
.	NULL

Scrum	NULL
responsive	NULL
gene	NULL
expression	NULL
mediated	NULL
by	NULL
Sp1	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

252:517-523	NULL
.	NULL

Kumar	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
A.	NULL
P.	NULL
Butler	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factor	NULL
Sp3	NULL
antagonizes	NULL
activation	NULL
of	NULL
the	NULL
ornithine	NULL
decarboxylase	NULL
promoter	NULL
by	NULL
Sp1	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

25:2012-2019	NULL
.	NULL

Le	NULL
Roux	NULL
,	NULL
F.	NULL
,	NULL
A	NULL
.	NULL

Sergeant	NULL
,	NULL
and	NULL
L	NULL
Corbo	NULL
.	NULL

1996	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
EB1/Zta	NULL
protein	NULL
provided	NULL
in	NULL
trans	NULL
and	NULL
competent	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
productive	NULL
cycle	NULL
genes	NULL
does	NULL
not	NULL
activate	NULL
the	NULL
BZLF1	NULL
gene	NULL
in	NULL
the	NULL
EBV	NULL
ge-nome	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

77:501-509	NULL
.	NULL

Li	NULL
,	NULL
Q.	NULL
X.	NULL
,	NULL
L.	NULL
S.	NULL
Young	NULL
,	NULL
G.	NULL
Niedobitek	NULL
,	NULL
C.	NULL
W.	NULL
D	NULL
,	NULL
M.	NULL
Birkenbach	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1992	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
infection	NULL
and	NULL
replication	NULL
in	NULL
a	NULL
human	NULL
epithelial	NULL
cell	NULL
system	NULL
.	NULL

Nature	NULL
356:347-350	NULL
.	NULL

Liang	NULL
,	NULL
Y.	NULL
,	NULL
D.	NULL
F.	NULL
Robinson	NULL
,	NULL
J.	NULL
Dennig	NULL
,	NULL
G.	NULL
Suske	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Fahl	NULL
,	NULL
1996	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
SIS/PDGF-B	NULL
gene	NULL
in	NULL
human	NULL
osteosarcoma	NULL
cells	NULL
by	NULL
the	NULL
Sp	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:11792-11797	NULL
.	NULL

Liang	NULL
,	NULL
Y.	NULL
,	NULL
D.	NULL
F.	NULL
Robinson	NULL
,	NULL
G.	NULL
C.	NULL
Kujoth	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Fahl	NULL
.	NULL

1996	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
SIS	NULL
proximal	NULL
element	NULL
and	NULL
its	NULL
activating	NULL
factors	NULL
:	NULL
regulated	NULL
transcription	NULL
of	NULL
the	NULL
c-SIS/PDGF-B	NULL
gene	NULL
in	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Oncogene	NULL
13:863-871	NULL
.	NULL

Lin	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
A.	NULL
R.	NULL
Black	NULL
,	NULL
D.	NULL
Kostic	NULL
,	NULL
S.	NULL
Pajovic	NULL
,	NULL
C.	NULL
N.	NULL
Hoover	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Azizkhan	NULL
.	NULL

1996	NULL
.	NULL

Cell	NULL
cycle-regulated	NULL
association	NULL
of	NULL
E2F1	NULL
and	NULL
Sp1	NULL
is	NULL
related	NULL
to	NULL
their	NULL
functional	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1668-1675	NULL
.	NULL

Liu	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
D.	NULL
Sista	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pagano	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
DNA	NULL
polymerase	NULL
promoter	NULL
by	NULL
the	NULL
BRLF1	NULL
immediate-early	NULL
protein	NULL
is	NULL
mediated	NULL
through	NULL
USF	NULL
and	NULL
E2F	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:2545-2555	NULL
.	NULL

Liu	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Borras	NULL
,	NULL
P.	NULL
Liu	NULL
,	NULL
G.	NULL
Suske	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Speck	NULL
.	NULL

1997	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
ubiquitous	NULL
cellular	NULL
transcription	NULL
factors	NULL
Sp1	NULL
and	NULL
Sp3	NULL
to	NULL
the	NULL
ZI	NULL
domains	NULL
in	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
lytic	NULL
switch	NULL
BZLF1	NULL
gene	NULL
promoter	NULL
.	NULL

Virology	NULL
228:11-18	NULL
.	NULL

Macleod	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Charlton	NULL
,	NULL
J.	NULL
Mullins	NULL
,	NULL
and	NULL
A.	NULL
P.	NULL
Bird	NULL
.	NULL

1994	NULL
.	NULL

Sp1	NULL
sites	NULL
in	NULL
the	NULL
mouse	NULL
aprt	NULL
gene	NULL
promoter	NULL
are	NULL
required	NULL
to	NULL
prevent	NULL
methylation	NULL
of	NULL
the	NULL
CpG	NULL
island	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:2282-2292	NULL
.	NULL

Majello	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
De	NULL
Luca	NULL
,	NULL
G.	NULL
Hagen	NULL
,	NULL
G.	NULL
Suske	NULL
,	NULL
and	NULL
L.	NULL
Lania	NULL
.	NULL

1994	NULL
.	NULL

Different	NULL
members	NULL
of	NULL
the	NULL
Sp1	NULL
multigene	NULL
family	NULL
exert	NULL
opposite	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
HIV-1	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:4914-4921	NULL
.	NULL

Majello	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
De	NULL
Luca	NULL
,	NULL
and	NULL
L.	NULL
Lania	NULL
.	NULL

1997	NULL
.	NULL

Sp3	NULL
is	NULL
a	NULL
bifunctional	NULL
transcription	NULL
regulator	NULL
with	NULL
modular	NULL
independent	NULL
activation	NULL
and	NULL
repression	NULL
domains	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:4021-4026	NULL
.	NULL

Majello	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
De	NULL
Luca	NULL
,	NULL
G.	NULL
Suske	NULL
,	NULL
and	NULL
L.	NULL
Lania	NULL
.	NULL

1995	NULL
.	NULL

Differential	NULL
transcriptional	NULL
regulation	NULL
of	NULL
c-myc	NULL
promoter	NULL
through	NULL
the	NULL
same	NULL
DNA	NULL
binding	NULL
sites	NULL
targeted	NULL
by	NULL
Sp1-like	NULL
proteins	NULL
.	NULL

Oncogene	NULL
10:1841-1848	NULL
.	NULL

McKnight	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
T.	NULL
M.	NULL
Kristie	NULL
,	NULL
and	NULL
B.	NULL
Roizman	NULL
.	NULL

1987	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
virion	NULL
protein	NULL
mediating	NULL
alpha	NULL
gene	NULL
induction	NULL
in	NULL
herpes	NULL
simplex	NULL
virus	NULL
1-infected	NULL
cells	NULL
to	NULL
its	NULL
cis	NULL
site	NULL
requires	NULL
cellular	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:7061-7065	NULL
.	NULL

Merchant	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
M.	NULL
Du	NULL
,	NULL
and	NULL
A.	NULL
Todisco	NULL
.	NULL

1999	NULL
.	NULL

Sp1	NULL
phosphorylation	NULL
by	NULL
Erk	NULL
2	NULL
stimulates	NULL
DNA	NULL
binding	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

254:454-461	NULL
.	NULL

Miller	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
M.	NULL
Lipman	NULL
.	NULL

1973	NULL
.	NULL

Release	NULL
of	NULL
infectious	NULL
Epstein-Barr	NULL
virus	NULL
by	NULL
transformed	NULL
marmoset	NULL
leukocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
70:190-194	NULL
.	NULL

Mimori	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Hardin	NULL
.	NULL

1986	NULL
.	NULL

Mechanism	NULL
of	NULL
interaction	NULL
between	NULL
Ku	NULL
protein	NULL
and	NULL
DNA	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

261:10375-10379	NULL
.	NULL

Miyashita	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
B.	NULL
Yang	NULL
,	NULL
K.	NULL
M.	NULL
Lam	NULL
,	NULL
D.	NULL
H.	NULL
Crawford	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Thorley-Lawson	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
novel	NULL
form	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latency	NULL
in	NULL
normal	NULL
B	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
80:593-601	NULL
.	NULL

Montalvo	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
M.	NULL
Cottam	NULL
,	NULL
S.	NULL
Hill	NULL
,	NULL
and	NULL
Y.	NULL
J.	NULL
Wang	NULL
.	NULL

1995	NULL
.	NULL

YY1	NULL
binds	NULL
to	NULL
and	NULL
regulates	NULL
cis-acting	NULL
negative	NULL
elements	NULL
in	NULL
the	NULL
Epstein-	NULL
Barr	NULL
virus	NULL
BZLF1	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:4158-4165	NULL
.	NULL

Mosser	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
N.	NULL
G.	NULL
Theodorakis	NULL
,	NULL
and	NULL
R.	NULL
I.	NULL
Morimoto	NULL
.	NULL

1988	NULL
.	NULL

Coordinate	NULL
changes	NULL
in	NULL
heat	NULL
shock	NULL
element-binding	NULL
activity	NULL
and	NULL
HSP70	NULL
gene	NULL
transcription	NULL
rates	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

84736-4744	NULL
.	NULL

Muller	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Gissmann	NULL
,	NULL
R.	NULL
J.	NULL
Cristiano	NULL
,	NULL
X.	NULL
Y	NULL
.	NULL

Sun	NULL
,	NULL
I.	NULL
H.	NULL
Frazer	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Jenson	NULL
,	NULL
A.	NULL
Alonso	NULL
,	NULL
H.	NULL
Zentgraf	NULL
,	NULL
and	NULL
J.	NULL
Zhou	NULL
.	NULL

1995	NULL
.	NULL

Papillomavirus	NULL
capsid	NULL
61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

AUTOSTIMULATION	NULL
OF	NULL
EBV	NULL
BRLFI	NULL
PROMOTER	NULL
5251	NULL
binding	NULL
and	NULL
uptake	NULL
by	NULL
cells	NULL
from	NULL
different	NULL
tissues	NULL
and	NULL
species	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:948-954	NULL
.	NULL

Pulvertaft	NULL
,	NULL
R.	NULL
J.	NULL
V.	NULL
1964	NULL
.	NULL

Cytology	NULL
of	NULL
Burkitt	NULL
's	NULL
tumor	NULL
(	NULL
African	NULL
lymphoma	NULL
)	NULL
.	NULL

Lancet	NULL
1238-240	NULL
.	NULL

Rabson	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Heston	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1983	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
rare	NULL
Epstein-Barr	NULL
virus	NULL
variant	NULL
that	NULL
enhances	NULL
carly	NULL
antigen	NULL
expression	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:2762-2766	NULL
.	NULL

Ragoczy	NULL
,	NULL
T.	NULL
,	NULL
L.	NULL
Heston	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
Ria	NULL
protein	NULL
activates	NULL
lytic	NULL
cycle	NULL
genes	NULL
and	NULL
can	NULL
disrupt	NULL
latency	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:7978-7984	NULL
.	NULL

Ragoczy	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1999	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
Rta	NULL
protein	NULL
in	NULL
activation	NULL
of	NULL
distinct	NULL
classes	NULL
of	NULL
viral	NULL
lytic	NULL
cycle	NULL
genes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

73:9858-9866	NULL
.	NULL

Roden	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
R.	NULL
Kirnb	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
J	NULL
D.	NULL
R.	NULL
Lowy	NULL
,	NULL
and	NULL
J.	NULL
T.	NULL
Schiller	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
papillomaviruses	NULL
with	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:7260-7266	NULL
.	NULL

Roblff	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
Ahmad	NULL
,	NULL
F.	NULL
Borellini	NULL
,	NULL
J.	NULL
Lei	NULL
,	NULL
and	NULL
R.	NULL
I.	NULL
Glazer	NULL
.	NULL

1997	NULL
.	NULL

Modulation	NULL
of	NULL
transcription	NULL
factor	NULL
Sp1	NULL
by	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:21137-21141	NULL
.	NULL

Rotheneder	NULL
,	NULL
H.	NULL
,	NULL
S.	NULL
Geymayer	NULL
,	NULL
and	NULL
E.	NULL
Haidweger	NULL
.	NULL

1999	NULL
.	NULL

Transcription	NULL
factors	NULL
of	NULL
the	NULL
Sp1	NULL
family	NULL
:	NULL
interaction	NULL
with	NULL
E2F	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
murine	NULL
thymi-dine	NULL
kinase	NULL
promoter	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

293:1005-1015	NULL
.	NULL

Schafer	NULL
,	NULL
D.	NULL
,	NULL
B.	NULL
Hamm-Kunzelmann	NULL
,	NULL
and	NULL
K.	NULL
Brand	NULL
.	NULL

1997	NULL
.	NULL

Glucose	NULL
regulates	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
aldolase	NULL
A	NULL
and	NULL
pyruvate	NULL
kinase	NULL
M2	NULL
via	NULL
dephosphor-ylation	NULL
of	NULL
Sp1	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

417:325-328	NULL
.	NULL

Serio	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
J.	NULL
L.	NULL
Kolman	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1997	NULL
.	NULL

Late	NULL
gene	NULL
expression	NULL
from	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BcLF1	NULL
and	NULL
BFRF3	NULL
promoters	NULL
does	NULL
not	NULL
require	NULL
DNA	NULL
replication	NULL
in	NULL
cis	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:8726-8734	NULL
.	NULL

Sinclair	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
M.	NULL
Bri	NULL
I1	NULL
,	NULL
F.	NULL
Shanahan	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1991	NULL
.	NULL

Pathways	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
productive	NULL
cycle	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:2237-2244	NULL
.	NULL

Sixbey	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
J.	NULL
G.	NULL
Nedrud	NULL
,	NULL
N.	NULL
Raab-Traub	NULL
,	NULL
R.	NULL
A.	NULL
Hanes	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pagano	NULL
.	NULL

1984	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
replication	NULL
in	NULL
oropharyngeal	NULL
epithelial	NULL
cells	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

310:1225-1230	NULL
.	NULL

Spain	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
R.	NULL
Sun	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
locus	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
terminal	NULL
repeat	NULL
processing	NULL
is	NULL
bound	NULL
with	NULL
enhanced	NULL
affinity	NULL
by	NULL
Sp1	NULL
and	NULL
Sp3	NULL
.	NULL

Virology	NULL
237:137-147	NULL
.	NULL

Speck	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
T.	NULL
Chatila	NULL
,	NULL
and	NULL
E.	NULL
Flemington	NULL
.	NULL

1997	NULL
.	NULL

Reactivation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
:	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
the	NULL
BZLF1	NULL
gene	NULL
.	NULL

Trends	NULL
Microbiol	NULL
.	NULL

5:399-405	NULL
.	NULL

Stern	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Tanaka	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
Oct-1	NULL
homeodomain	NULL
directs	NULL
formation	NULL
of	NULL
a	NULL
multiprotein-DNA	NULL
complex	NULL
with	NULL
the	NULL
HSV	NULL
transactivator	NULL
VP16	NULL
.	NULL

Nature	NULL
341:624-630	NULL
.	NULL

Suske	NULL
,	NULL
G.	NULL
1999	NULL
.	NULL

The	NULL
Sp-family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Gene	NULL
238:291-300	NULL
.	NULL

Takada	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Y.	NULL
Ono	NULL
.	NULL

1989	NULL
.	NULL

Synchronous	NULL
and	NULL
sequential	NULL
activation	NULL
of	NULL
latently	NULL
infected	NULL
Epstein-Barr	NULL
virus	NULL
genomes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:445-449	NULL
.	NULL

Thottassery	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
D.	NULL
Sun	NULL
,	NULL
G.	NULL
P.	NULL
Zambetti	NULL
,	NULL
A.	NULL
Troutman	NULL
,	NULL
V.	NULL
P.	NULL
Sukbatme	NULL
,	NULL
E.	NULL
G.	NULL
Schuetz	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Schuetz	NULL
.	NULL

1999	NULL
.	NULL

Sp1	NULL
and	NULL
egr-1	NULL
have	NULL
opposing	NULL
effects	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
rat	NULL
Pgp2/mdr1b	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:3199-3206	NULL
.	NULL

Udvadia	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
D.	NULL
J.	NULL
Templeton	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Horowitz	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
interactions	NULL
between	NULL
the	NULL
retinoblastoma	NULL
(	NULL
Rb	NULL
)	NULL
protein	NULL
and	NULL
Sp-	NULL
family	NULL
mem-bers	NULL
:	NULL
superactivation	NULL
by	NULL
Rb	NULL
requires	NULL
amino	NULL
acids	NULL
necessary	NULL
for	NULL
growth	NULL
sup-pression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:3953-3957	NULL
.	NULL

Waltzer	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Y.	NULL
Bourillot	NULL
,	NULL
A	NULL
.	NULL

Sergeant	NULL
,	NULL
and	NULL
E.	NULL
Manet	NULL
.	NULL

1995	NULL
.	NULL

RBP-J	NULL
kappa	NULL
repression	NULL
activity	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
co-repressor	NULL
and	NULL
antagonized	NULL
by	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transcription	NULL
factor	NULL
EBNA2	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23:4939-4945	NULL
.	NULL

Weigel	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1983	NULL
.	NULL

Major	NULL
EB	NULL
virus-specific	NULL
cytoplasmic	NULL
transcripts	NULL
in	NULL
a	NULL
cellular	NULL
clone	NULL
of	NULL
the	NULL
HR-1	NULL
Burkitt	NULL
lymphoma	NULL
line	NULL
during	NULL
latency	NULL
and	NULL
after	NULL
induction	NULL
of	NULL
viral	NULL
replicative	NULL
cycle	NULL
by	NULL
phorbol	NULL
esters	NULL
.	NULL

Virology	NULL
125:287-298	NULL
.	NULL

Xiao	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Hasegawa	NULL
,	NULL
and	NULL
K.	NULL
Isobe	NULL
.	NULL

2000.	NULL
p300	NULL
collaborates	NULL
with	NULL
Sp1	NULL
and	NULL
Sp3	NULL
in	NULL
p21	NULL
(	NULL
wafl/cip1	NULL
)	NULL
promoter	NULL
activation	NULL
induced	NULL
by	NULL
histone	NULL
deacetylase	NULL
inhibitor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275:1371-1376	NULL
.	NULL

Xiao	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Capone	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
cellular	NULL
factor	NULL
binds	NULL
to	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
transactivator	NULL
Vmw65	NULL
and	NULL
is	NULL
required	NULL
for	NULL
Vmw65-dependent	NULL
protein-DNA	NULL
complex	NULL
assembly	NULL
with	NULL
Oct-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:4974-4977	NULL
.	NULL

Zacay	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
J.	NULL
Wilson	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pagano	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
immediate-carly	NULL
gene	NULL
product	NULL
BRLF1	NULL
interacts	NULL
with	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
during	NULL
the	NULL
viral	NULL
lytic	NULL
cycle	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:8043-8051	NULL
.	NULL

Zalani	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Coppage	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
cellular	NULL
YY1	NULL
transcription	NULL
factor	NULL
binds	NULL
a	NULL
cis-acting	NULL
,	NULL
negatively	NULL
regulating	NULL
element	NULL
in	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BRLF1	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:3268-3274	NULL
.	NULL

Zalani	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Zif268	NULL
cellular	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
immediate-carly	NULL
BRLF1	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:3816-3823	NULL
.	NULL

Zalani	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
A.	NULL
Holley-Guthrie	NULL
,	NULL
D.	NULL
E.	NULL
Gutsch	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Kenney	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
immediate-early	NULL
promoter	NULL
BRLF1	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
the	NULL
cellular	NULL
Sp1	NULL
transcription	NULL
factor	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:7282-7292	NULL
.	NULL

Zhang	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
K.	NULL
H.	NULL
Kim	NULL
.	NULL

1997	NULL
.	NULL

Protein	NULL
kinase	NULL
CK2	NULL
down-regulates	NULL
glucose-activated	NULL
expression	NULL
of	NULL
the	NULL
acetyl-CoA	NULL
carboxylase	NULL
gene	NULL
.	NULL

Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

338:227-232	NULL
.	NULL

